TSS:Rfhg 182760.1

Basic information about the TSS

---

TSS ID: rfhg_182760.1 Species: human Chr: chr16		Start: 29859441 End: 29859441 Strand: -
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	-
Category:	-

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000567459.1:-28 GeneID: 10423 HGNC/MGI_ID: HGNC:1769 UniProt_ID: Nearer transcript ids and distances:

Gene_name: CDP-diacylglycerol--inositol 3-phosphatidyltransferase Gene_symbol: CDIPT Gene_synonyms: PIS PIS1 Gene_source: HGNC:1769

TATA-Box annotation

---

Distance to TSS:	3785
Nearest PromoterID:	NM_001286586
Entrez ID:	10423
Nearest Unigene:	Hs.121549
Nearest Refseq:	NM_006319
Nearest Ensembl:	ENSG00000103502
Gene Name:	CDP-diacylglycerol--inositol 3-phosphatidyltransferase
Gene Alias:	PIS|PIS1
Gene Type:	protein-coding
CpG%:	0.000000
GC%:	1.000000
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@CDIPT p2@CDIPT p3@CDIPT p4@CDIPT p5@CDIPT
Sample		p1@CDIPT	p2@CDIPT	p3@CDIPT	p4@CDIPT	p5@CDIPT
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	33.31	1.17	0.58	0.39	0.97
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	36.21	1.01	0.40	0.20	0.81
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	36.84	1.16	0.00	0.39	0.77
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	31.39	0.62	0.42	0.00	0.83
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	33.74	2.47	0.22	0.00	0.67
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	28.88	2.13	0.58	0.19	0.19
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	54.91	2.83	0.22	0.22	0.87
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	59.59	2.66	1.94	0.00	0.48
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	62.83	3.63	0.85	0.85	0.85
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	34.20	1.16	0.00	0.00	2.32
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	33.15	0.40	0.81	0.00	0.40
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	39.03	1.22	1.22	0.41	1.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	26.92	1.29	1.29	0.81	0.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	27.51	1.35	0.45	0.60	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	23.93	1.76	1.32	0.22	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	24.90	1.01	1.26	0.50	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	22.06	1.09	0.87	1.09	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	21.93	1.27	1.69	1.27	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	28.79	0.53	1.60	0.53	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	26.78	1.81	0.60	0.75	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	25.79	1.47	1.47	1.20	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	30.38	0.86	1.04	1.04	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	22.75	0.65	0.90	0.39	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	28.15	1.70	2.18	0.49	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	24.77	1.29	0.77	1.29	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	26.27	1.90	1.90	1.27	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	27.47	0.00	0.55	0.55	0.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	31.83	0.47	1.18	1.41	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	25.84	1.29	0.97	0.81	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	22.08	1.81	1.81	0.54	0.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	21.56	0.84	1.26	0.63	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	21.30	1.17	0.98	0.78	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	24.27	1.69	0.84	1.06	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	24.74	0.99	0.66	1.48	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	20.38	0.37	1.31	0.56	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	21.65	0.38	1.15	0.77	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	19.82	2.04	1.43	0.41	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	21.56	2.01	1.41	0.40	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	22.42	1.08	1.08	0.54	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	22.81	0.48	1.44	0.48	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	20.70	0.47	1.18	0.94	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	22.25	0.73	1.32	0.73	0.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	22.35	0.42	1.69	1.90	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	17.66	0.17	1.40	0.70	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	16.66	0.80	1.61	2.21	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	22.10	0.93	0.93	0.47	0.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	19.91	1.44	0.24	0.48	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	20.86	1.19	1.79	0.30	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	20.59	0.96	1.20	0.96	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	21.03	0.61	1.42	0.81	0.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	23.57	0.82	1.23	1.23	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	22.46	1.33	0.67	0.67	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	27.98	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	15.61	0.35	0.71	1.06	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	16.57	1.99	0.99	0.33	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	8.39	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	22.50	0.00	0.92	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	19.45	0.97	1.30	0.65	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	12.53	0.64	0.96	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	17.60	0.31	0.94	1.26	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	16.22	0.71	2.82	1.41	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	17.95	1.12	0.56	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	11.15	2.39	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	16.99	0.00	0.00	0.00	1.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	18.85	0.65	0.97	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	17.39	0.00	1.42	1.06	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	16.16	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	23.69	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	20.48	0.49	1.95	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	20.33	0.00	0.99	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	12.20	1.41	0.00	0.00	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	18.22	0.66	0.33	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	19.18	0.93	0.00	0.31	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	18.96	2.45	0.31	0.92	0.00
Adipocyte - breast, donor1	11376-118A8	85.69	3.64	1.58	1.58	0.63
Adipocyte - breast, donor2	11327-117E4	57.27	3.53	0.80	1.12	0.64
Adipocyte - omental, donor1	11473-119C6	83.72	4.96	1.91	1.02	0.89
Adipocyte - omental, donor2	11474-119C7	62.79	2.99	0.75	5.23	1.49
Adipocyte - omental, donor3	11475-119C8	49.90	5.02	1.00	1.00	0.33
Adipocyte - perirenal, donor1	11476-119C9	53.59	2.55	3.83	2.55	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	36.28	1.10	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	63.23	5.42	0.90	0.45	1.35
Adipocyte - subcutaneous, donor3	11408-118E4	72.99	5.04	0.35	0.52	0.70
Adipocyte differentiation, day04, donor1	13019-139D4	73.34	9.58	0.98	0.78	3.72
Adipocyte differentiation, day04, donor2	13022-139D7	48.90	4.89	0.77	0.51	1.03
Adipocyte differentiation, day04, donor3	13025-139E1	60.77	7.53	0.28	0.56	0.84
Adipocyte differentiation, day04, donor4	13028-139E4	56.43	4.70	0.00	1.76	1.18
Adipocyte differentiation, day08, donor1	13020-139D5	37.24	2.57	0.64	0.64	1.21
Adipocyte differentiation, day08, donor2	13023-139D8	48.41	3.55	1.94	0.97	1.94
Adipocyte differentiation, day08, donor3	13026-139E2	47.45	2.13	0.00	0.53	1.07
Adipocyte differentiation, day08, donor4	13029-139E5	38.39	2.23	0.56	0.00	0.56
Adipocyte differentiation, day12, donor1	13021-139D6	41.59	2.91	0.00	0.42	0.42
Adipocyte differentiation, day12, donor2	13024-139D9	45.46	3.01	0.50	1.00	1.26
Adipocyte differentiation, day12, donor3	13027-139E3	43.52	2.29	0.65	0.98	0.98
Adipocyte differentiation, day12, donor4	13030-139E6	28.92	2.13	0.30	0.00	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	33.37	2.87	1.33	0.22	1.10
Alveolar Epithelial Cells, donor2	11590-120G6	50.20	2.87	2.87	1.08	1.08
Alveolar Epithelial Cells, donor3	11671-122G6	29.95	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	33.28	0.36	0.36	0.90	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	30.12	1.67	0.00	0.00	1.67
Amniotic Epithelial Cells, donor3	11694-123A2	24.65	1.03	0.82	1.23	0.21
Anulus Pulposus Cell, donor1	11248-116E6	64.65	2.52	1.14	0.57	0.57
Anulus Pulposus Cell, donor2	11463-119B5	62.21	3.43	2.20	1.22	0.24
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	34.60	1.35	1.80	2.70	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	45.58	2.60	2.17	2.17	0.87
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	47.09	0.00	0.00	4.28	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	34.38	1.20	1.20	1.49	0.30
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	44.26	1.26	0.00	2.53	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	41.58	2.64	1.98	1.98	1.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	34.11	2.92	0.32	0.97	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	37.38	0.97	3.40	1.46	0.97
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	38.60	2.38	0.59	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	35.40	2.64	1.51	1.88	1.13
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	34.11	0.73	0.73	0.73	0.73
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	28.84	1.25	1.25	3.76	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	37.89	3.13	1.48	1.65	0.66
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	36.85	1.36	1.36	1.36	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	34.53	3.47	0.75	1.51	0.45
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	34.29	0.54	0.54	2.68	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	35.71	2.65	0.76	2.83	0.38
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	41.96	2.94	1.34	0.27	0.27
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	46.82	1.95	0.98	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	35.66	1.82	1.49	1.00	0.33
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	58.84	1.20	1.20	1.20	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	31.86	0.00	3.54	7.08	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	44.25	2.57	1.20	1.20	0.17
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	29.36	4.19	4.19	4.19	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	42.23	1.46	2.43	1.46	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	42.12	3.04	1.90	1.52	1.90
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	43.61	3.63	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	29.07	3.42	1.14	0.57	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	37.41	2.78	1.50	1.28	0.86
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	41.04	2.58	2.06	1.81	0.26
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	38.01	0.94	1.41	1.41	0.94
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	41.80	2.25	1.61	1.29	0.96
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	35.67	1.43	2.14	2.85	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	37.44	4.09	0.00	0.58	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	36.73	1.81	0.30	1.20	1.81
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	26.14	0.00	1.19	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	33.56	2.03	1.53	2.54	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	41.26	3.82	1.53	0.25	0.25
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	34.95	0.64	0.00	3.18	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	36.68	3.45	0.86	0.43	1.29
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	33.45	3.81	1.91	0.42	0.21
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	38.57	3.48	0.87	1.45	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	31.18	1.89	0.00	1.89	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	34.24	1.70	2.54	1.36	0.85
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	39.38	0.00	0.00	2.32	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	33.80	2.11	2.11	2.11	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	34.52	2.57	1.50	1.29	0.64
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	34.29	1.80	3.01	1.20	0.60
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	38.64	2.19	0.00	2.92	0.73
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	40.46	2.30	1.84	1.38	0.92
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	25.50	2.55	7.65	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	38.90	3.81	2.03	0.76	0.76
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	38.60	2.48	2.06	1.03	0.62
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	36.41	1.22	2.45	0.92	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	46.85	2.87	0.48	0.96	0.96
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	39.47	2.22	1.33	1.55	1.11
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	41.20	4.58	1.53	1.53	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	44.31	1.66	0.55	1.66	1.11
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	41.04	2.38	0.79	1.59	1.32
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	42.52	3.27	1.09	0.36	0.73
Astrocyte - cerebellum, donor1	11500-119F6	22.97	1.47	1.97	1.97	0.49
Astrocyte - cerebellum, donor2	11580-120F5	31.49	2.23	2.57	3.25	0.86
Astrocyte - cerebellum, donor3	11661-122F5	25.59	0.84	2.94	1.68	0.42
Astrocyte - cerebral cortex, donor1	11235-116D2	16.03	1.39	0.70	1.05	0.35
Astrocyte - cerebral cortex, donor2	11316-117D2	22.97	0.49	0.97	0.49	0.32
Astrocyte - cerebral cortex, donor3	11392-118C6	18.05	1.04	0.89	0.45	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	14.34	0.00	0.23	0.00	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	15.28	0.38	0.38	0.13	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	14.79	0.11	0.23	0.23	0.00
Basophils, donor1	12241-129G9	23.28	1.83	0.26	0.26	0.00
Basophils, donor2	12242-129H1	19.48	0.00	0.00	0.00	0.36
Basophils, donor3	12243-129H2	19.84	0.73	0.00	0.44	0.59
Bronchial Epithelial Cell, donor1	11511-119G8	27.17	2.59	0.22	0.22	0.22
Bronchial Epithelial Cell, donor2	11591-120G7	54.86	5.03	1.37	0.00	0.46
Bronchial Epithelial Cell, donor3	11672-122G7	21.52	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	23.22	0.63	0.00	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	22.46	1.66	0.21	1.04	0.21
Bronchial Epithelial Cell, donor6	11461-119B3	16.35	0.46	0.00	0.00	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	34.91	0.90	0.18	0.54	0.18
Burkitt's lymphoma cell line:DAUDI	10422-106C8	16.39	0.41	0.93	0.00	0.31
Burkitt's lymphoma cell line:RAJI	10476-106I8	19.80	0.70	0.70	0.70	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	47.01	0.96	3.84	0.32	0.32
CD133+ stem cells - cord blood derived, pool1	12223-129E9	31.03	0.00	10.34	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	30.43	1.13	0.00	0.00	0.00
CD14+ Monocytes, donor2	11305-117B9	15.96	0.56	0.19	0.00	0.00
CD14+ Monocytes, donor3	11381-118B4	22.17	1.76	0.22	0.22	0.22
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	50.10	1.98	0.85	0.00	0.28
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	42.08	3.03	0.38	0.38	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	50.95	1.31	0.66	0.33	0.33
CD14+ monocytes - mock treated, donor1	11863-125A9	30.36	1.16	0.29	0.00	0.14
CD14+ monocytes - mock treated, donor2	11873-125C1	11.16	0.91	0.00	0.00	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	18.95	0.71	0.24	0.00	0.24
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	10.21	0.33	0.00	0.00	0.17
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	6.35	0.28	0.00	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	4.71	0.25	0.00	0.00	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	23.69	2.74	0.00	0.39	1.37
CD14+ monocytes - treated with BCG, donor2	11870-125B7	16.20	1.25	0.00	0.00	0.71
CD14+ monocytes - treated with BCG, donor3	11880-125C8	23.94	2.39	0.00	0.22	1.31
CD14+ monocytes - treated with Candida, donor1	11868-125B5	11.00	0.70	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	6.86	0.53	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	14.42	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	17.25	0.59	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	7.38	0.20	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	11.66	0.62	0.21	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	11.44	0.92	0.00	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	7.46	0.00	0.23	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	9.17	0.00	0.44	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	35.51	4.30	0.00	0.00	1.61
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	31.05	6.11	0.00	0.17	1.05
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	36.61	5.47	0.00	0.00	1.68
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	9.74	0.37	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	6.69	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	3.51	0.44	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	19.88	2.09	0.17	0.00	0.35
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	12.64	0.74	0.00	0.00	0.74
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	20.69	3.23	0.22	0.00	0.65
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	10.24	0.82	0.00	0.41	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	6.72	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	6.96	0.93	0.00	0.00	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	32.04	1.09	0.00	0.00	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	37.65	1.85	0.00	0.00	0.46
CD14+CD16+ Monocytes, donor3	11912-125G4	33.36	1.95	0.43	0.00	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	47.03	1.87	0.16	0.00	0.16
CD14+CD16- Monocytes, donor2	11799-124C8	38.77	1.75	0.17	0.00	0.35
CD14+CD16- Monocytes, donor3	11910-125G2	33.67	0.89	0.45	0.00	0.45
CD14-CD16+ Monocytes, donor1	11790-124B8	40.57	3.06	0.00	0.00	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	42.82	3.73	0.00	0.22	0.22
CD14-CD16+ Monocytes, donor3	11911-125G3	34.32	1.68	0.00	0.00	0.42
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	42.68	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	40.00	0.00	0.00	0.68	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	36.25	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	42.11	0.53	0.00	0.53	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	30.56	0.54	0.54	0.00	0.54
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	35.80	0.70	0.00	0.70	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	38.43	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	36.91	0.00	1.32	0.00	1.32
CD19+ B Cells, donor1	11544-120B5	22.19	0.00	0.00	0.82	0.00
CD19+ B Cells, donor2	11624-122B4	10.88	0.00	0.73	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	9.59	0.00	0.00	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	40.00	1.21	0.40	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	45.14	1.60	1.60	0.40	0.40
CD34+ Progenitors, donor1	11545-120B6	11.04	2.01	3.01	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	13.48	0.00	1.12	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	30.44	2.25	2.25	1.13	0.75
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	36.98	0.68	1.35	0.68	0.00
CD4+ T Cells, donor1	11225-116C1	18.57	0.71	0.00	0.00	0.00
CD4+ T Cells, donor2	11306-117C1	30.01	0.00	0.00	1.22	0.00
CD4+ T Cells, donor3	11382-118B5	26.53	0.61	0.61	0.30	0.30
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	43.13	0.26	1.02	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	50.98	1.12	1.35	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	53.18	1.15	1.15	0.57	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	49.78	0.47	0.00	0.95	0.47
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	61.80	0.70	0.70	0.00	0.70
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	59.33	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	46.24	0.87	0.29	0.43	0.14
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	42.54	0.51	0.85	1.02	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	46.27	0.81	0.64	0.81	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	40.80	0.45	0.45	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	48.91	1.75	0.00	0.35	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	39.60	0.44	0.44	0.44	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	37.10	1.26	0.00	0.42	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	44.88	1.45	0.83	1.04	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	42.43	1.34	1.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	47.86	0.54	0.00	0.27	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	51.99	0.54	0.54	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	39.45	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	50.07	1.11	0.74	0.00	0.37
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	50.26	1.73	0.43	0.87	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	55.69	0.84	0.21	0.63	0.63
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	40.95	1.01	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	48.09	1.30	0.43	0.43	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	32.69	0.44	0.44	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	67.30	2.47	0.49	0.49	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	44.31	0.92	0.00	0.92	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	44.67	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	54.00	2.22	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	56.44	0.74	0.25	0.49	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	73.92	0.00	0.00	1.54	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	65.89	2.15	0.36	0.36	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	59.55	1.38	0.00	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	28.16	0.00	0.00	0.00	0.00
CD8+ T Cells, donor2	11307-117C2	19.15	0.75	0.00	0.00	0.38
CD8+ T Cells, donor3	11383-118B6	26.26	0.50	0.50	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	22.94	0.46	1.61	0.69	0.23
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	17.49	0.96	0.48	0.00	0.48
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	19.97	1.09	0.55	0.27	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	12.01	0.60	0.30	0.30	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	24.72	0.00	0.72	1.20	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	17.96	1.59	0.68	0.68	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	19.12	0.43	0.22	0.43	0.43
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	16.85	1.05	0.79	0.26	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	16.89	1.17	0.47	0.00	0.47
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	20.83	0.60	1.21	1.21	0.30
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	21.21	1.45	0.87	0.29	0.29
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	15.72	1.07	1.33	0.27	0.53
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	14.88	0.00	0.88	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	10.02	0.91	0.91	2.28	0.91
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	15.66	0.00	0.00	0.00	0.75
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	23.05	0.72	1.08	3.60	0.72
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	18.41	1.44	0.58	0.86	0.58
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	19.56	1.41	0.71	0.71	0.47
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	23.45	0.95	0.95	0.63	0.32
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	20.61	0.62	0.31	0.92	0.31
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	16.99	0.96	1.28	0.96	0.64
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	15.68	0.38	0.00	0.00	0.76
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	20.49	0.39	0.39	0.39	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	18.91	2.27	0.00	0.00	0.76
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	16.86	0.80	0.80	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	16.09	0.70	0.70	0.00	0.70
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	15.03	1.00	0.00	1.00	0.00
Cardiac Myocyte, donor1	11525-119I4	38.38	1.83	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	56.33	3.46	1.98	0.49	0.99
Cardiac Myocyte, donor3	11686-122I3	37.99	2.21	1.58	0.63	0.32
Chondrocyte - de diff, donor1	11261-116G1	37.44	1.73	0.35	1.39	0.69
Chondrocyte - de diff, donor2	11338-117F6	30.21	1.42	0.71	0.71	0.00
Chondrocyte - de diff, donor3	11410-118E6	61.44	3.87	1.02	0.80	0.68
Chondrocyte - re diff, donor2	11339-117F7	14.32	2.69	0.90	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	38.01	2.83	0.00	0.81	1.21
Ciliary Epithelial Cells, donor1	11242-116D9	23.18	0.23	1.03	0.69	0.46
Ciliary Epithelial Cells, donor2	11323-117D9	19.67	0.64	2.14	1.07	1.07
Ciliary Epithelial Cells, donor3	11399-118D4	19.91	1.15	0.53	1.06	0.35
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	61.62	2.02	1.19	2.11	0.73
Corneal Epithelial Cells, donor1	11526-119I5	38.21	2.85	0.44	0.22	0.66
Corneal Epithelial Cells, donor2	11606-120I4	46.64	2.28	0.00	1.14	0.00
Corneal Epithelial Cells, donor3	11687-122I4	36.56	4.86	0.00	0.26	1.79
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	43.42	1.65	0.99	0.66	0.17
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	45.73	1.89	0.63	0.63	0.32
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	48.31	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	40.93	1.94	0.86	0.97	0.43
Dendritic Cells - plasmacytoid, donor1	11228-116C4	25.96	3.42	0.00	0.00	0.34
Dendritic Cells - plasmacytoid, donor2	11309-117C4	16.32	1.31	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	22.75	1.45	0.48	0.00	0.97
Endothelial Cells - Aortic, donor0	11207-116A1	20.35	0.67	0.33	0.67	0.67
Endothelial Cells - Aortic, donor1	11263-116G3	18.19	0.59	1.17	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	32.52	1.98	1.41	0.57	0.85
Endothelial Cells - Aortic, donor3	11412-118E8	22.41	0.00	1.57	1.57	0.00
Endothelial Cells - Artery, donor1	11264-116G4	35.78	2.91	0.87	0.58	0.29
Endothelial Cells - Artery, donor2	11341-117F9	44.47	0.71	1.41	0.47	0.24
Endothelial Cells - Artery, donor3	11413-118E9	22.09	0.53	1.23	0.88	0.35
Endothelial Cells - Lymphatic, donor1	11236-116D3	23.50	1.77	1.77	0.22	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	23.43	0.30	0.61	2.13	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	12.69	0.56	0.56	0.28	0.56
Endothelial Cells - Microvascular, donor1	11265-116G5	18.42	2.08	1.19	0.00	0.30
Endothelial Cells - Microvascular, donor2	11342-117G1	21.87	1.04	1.56	1.04	0.52
Endothelial Cells - Microvascular, donor3	11414-118F1	36.44	1.42	0.99	0.71	0.43
Endothelial Cells - Thoracic, donor1	11266-116G6	24.41	0.80	0.00	0.40	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	31.45	2.10	3.14	0.52	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	37.90	0.99	2.11	0.75	0.00
Endothelial Cells - Umbilical vein, donor2	11324-117E1	25.85	0.65	1.52	0.00	0.65
Endothelial Cells - Umbilical vein, donor3	11400-118D5	27.36	0.98	1.10	0.49	0.12
Endothelial Cells - Vein, donor1	11267-116G7	25.03	0.00	0.00	1.14	2.28
Endothelial Cells - Vein, donor2	11344-117G3	20.26	0.00	2.10	0.70	0.70
Endothelial Cells - Vein, donor3	11416-118F3	31.24	1.73	1.10	0.79	0.47
Eosinophils, donor1	12244-129H3	15.25	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	39.61	1.65	0.00	0.00	1.65
Eosinophils, donor3	12246-129H5	49.94	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	25.41	1.71	0.24	0.00	0.24
Esophageal Epithelial Cells, donor2	11587-120G3	24.96	2.08	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	16.27	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	28.33	0.82	1.64	1.64	1.23
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	47.08	2.30	1.64	2.19	0.77
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	44.64	1.95	1.08	0.43	0.54
Fibroblast - Aortic Adventitial, donor1	11245-116E3	34.93	0.85	0.85	0.97	0.12
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	24.70	1.77	0.96	0.82	0.27
Fibroblast - Aortic Adventitial, donor2	11326-117E3	38.07	2.74	1.79	1.05	1.05
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	37.68	1.32	0.79	0.79	0.53
Fibroblast - Aortic Adventitial, donor3	11401-118D6	43.52	2.99	1.33	0.33	1.33
Fibroblast - Cardiac, donor1	11268-116G8	41.28	2.72	1.81	0.45	0.00
Fibroblast - Cardiac, donor2	11345-117G4	31.83	0.76	0.00	0.76	0.00
Fibroblast - Cardiac, donor3	11417-118F4	43.06	1.26	2.68	1.58	1.26
Fibroblast - Cardiac, donor4	11452-119A3	29.40	1.52	0.61	1.21	0.30
Fibroblast - Cardiac, donor5	11456-119A7	27.28	1.78	0.76	0.89	0.00
Fibroblast - Cardiac, donor6	11460-119B2	31.99	1.21	0.91	0.30	0.15
Fibroblast - Choroid Plexus, donor1	11492-119E7	27.33	4.42	1.88	2.41	3.62
Fibroblast - Choroid Plexus, donor2	11572-120E6	32.36	2.59	0.86	1.29	1.73
Fibroblast - Choroid Plexus, donor3	11653-122E6	26.37	2.93	0.00	0.00	2.93
Fibroblast - Conjunctival, donor1	11531-120A1	20.53	0.46	0.46	1.38	0.46
Fibroblast - Conjunctival, donor3	11692-122I9	71.57	3.90	1.19	0.51	1.02
Fibroblast - Dermal, donor1	11269-116G9	35.22	3.29	0.94	0.23	1.64
Fibroblast - Dermal, donor2	11346-117G5	24.06	1.42	0.47	0.94	0.00
Fibroblast - Dermal, donor3	11418-118F5	47.39	3.02	0.73	0.48	0.97
Fibroblast - Dermal, donor4	11450-119A1	13.11	0.68	0.79	0.90	0.23
Fibroblast - Dermal, donor5	11454-119A5	12.91	0.52	1.22	0.70	0.17
Fibroblast - Dermal, donor6	11458-119A9	17.38	1.30	0.81	0.32	0.16
Fibroblast - Gingival, donor1	11237-116D4	24.36	1.67	1.25	0.42	0.21
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	49.26	1.05	1.05	0.52	0.26
Fibroblast - Gingival, donor2	11318-117D4	33.21	1.98	0.66	0.53	0.66
Fibroblast - Gingival, donor3	11394-118C8	28.14	2.42	0.29	0.87	1.26
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	54.02	4.16	0.00	0.00	2.08
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	51.10	2.82	1.23	0.18	0.53
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	37.88	2.96	1.25	0.16	0.62
Fibroblast - Gingival, donor6 (control)	11922-125H5	31.10	1.89	1.08	0.41	0.41
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	62.46	3.18	2.47	1.41	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	36.12	2.05	1.61	0.88	0.44
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	41.32	2.59	1.23	0.68	0.41
Fibroblast - Gingival, donor8 (control)	11926-125H9	36.64	1.10	1.32	0.66	0.11
Fibroblast - Gingival, donor9 (control)	11927-125I1	74.54	3.67	0.88	1.17	2.20
Fibroblast - Lung, donor1	11270-116H1	29.91	2.72	0.00	1.36	0.00
Fibroblast - Lung, donor2	11347-117G6	28.35	1.49	0.00	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	48.96	2.95	1.90	1.27	0.63
Fibroblast - Lymphatic, donor1	11506-119G3	26.66	5.00	0.83	0.83	1.67
Fibroblast - Lymphatic, donor2	11586-120G2	20.98	5.59	0.00	1.40	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	41.14	1.40	1.40	1.12	0.56
Fibroblast - Mammary, donor1	11540-120B1	39.78	2.03	0.00	0.81	0.81
Fibroblast - Mammary, donor2	11620-122A9	35.95	3.99	7.99	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	41.69	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	25.60	0.97	0.58	0.78	0.19
Fibroblast - Periodontal Ligament, donor2	11319-117D5	26.24	1.06	0.91	0.46	0.00
Fibroblast - Periodontal Ligament, donor3	11395-118C9	16.52	1.22	0.31	0.00	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	30.15	3.05	1.91	1.91	1.14
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	36.45	1.35	0.81	0.54	0.27
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	52.19	4.41	0.46	0.23	1.51
Fibroblast - Pulmonary Artery, donor1	11250-116E8	40.57	1.33	1.33	0.66	0.00
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	35.36	3.45	0.41	0.41	1.22
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	26.06	1.34	2.00	0.67	1.34
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	38.75	2.77	0.79	0.40	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	26.79	1.59	0.99	0.79	0.20
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	30.37	2.13	1.24	1.07	0.71
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	35.87	1.97	1.97	0.79	0.59
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	40.62	1.20	2.11	1.20	0.30
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	37.46	1.51	1.94	0.76	0.76
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	25.81	0.25	0.76	0.51	0.25
Fibroblast - skin normal, donor1	11553-120C5	37.41	2.63	0.66	2.13	0.33
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	29.68	2.01	0.80	1.00	0.60
Fibroblast - skin normal, donor2	11561-120D4	38.08	1.51	0.70	1.91	0.20
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	29.62	0.60	1.51	1.21	0.30
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	45.48	2.07	1.57	1.66	0.58
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	47.87	2.39	1.20	1.20	0.85
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	37.77	0.66	1.97	1.97	0.66
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	33.02	0.43	2.56	2.13	0.43
Fibroblast - skin walker warburg, donor1	11554-120C6	28.51	1.86	0.84	0.67	0.67
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	44.07	0.16	1.57	0.94	0.78
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	88.64	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	31.38	4.36	0.87	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	29.30	1.56	1.04	1.56	0.52
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	29.41	2.60	0.78	0.78	1.30
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	26.83	2.56	0.51	0.51	1.28
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	52.82	2.30	1.53	1.53	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	51.05	1.28	1.91	0.00	0.64
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	51.92	3.14	0.86	0.86	2.85
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	48.53	1.93	0.55	0.55	1.10
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	28.54	1.14	1.83	1.60	0.46
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	36.65	2.38	1.39	1.39	1.59
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	43.62	2.38	0.79	1.06	1.06
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	32.29	0.98	0.98	0.65	1.30
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	40.24	3.98	0.88	0.88	2.21
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	39.99	2.12	0.42	0.28	0.57
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	38.67	1.35	0.00	0.74	0.62
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	40.29	5.10	0.27	0.54	1.34
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	45.10	2.11	0.50	0.50	0.99
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	40.42	1.25	0.42	0.28	0.55
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	35.58	2.44	0.20	0.41	0.20
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	52.48	3.42	0.68	0.23	0.91
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	43.85	2.99	0.25	0.87	0.87
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	41.53	3.50	0.44	0.44	0.87
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	62.64	4.73	0.30	0.89	1.18
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	39.74	1.43	0.79	0.48	0.64
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	54.07	2.90	1.34	0.22	2.23
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	46.98	1.21	0.81	0.81	0.20
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	45.80	1.87	0.51	0.51	0.68
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	53.03	3.19	0.98	0.89	0.80
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	60.87	2.29	0.94	0.21	0.73
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	48.16	2.39	0.85	0.51	0.34
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	38.73	1.66	0.77	0.44	0.44
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	47.42	2.66	0.67	0.42	0.42
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	40.63	2.04	0.41	0.20	0.61
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	50.54	1.24	1.44	0.41	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	43.70	1.38	0.58	0.58	0.58
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	49.20	3.00	0.33	0.50	0.83
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	53.79	2.42	0.22	0.22	0.66
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	51.41	2.09	0.86	0.37	0.61
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	42.95	2.27	0.81	0.32	1.46
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	54.52	1.28	1.28	0.32	0.64
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	39.23	1.99	0.66	1.04	0.57
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	44.61	2.69	0.79	0.63	0.47
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	56.56	1.82	0.91	0.91	1.22
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	43.49	3.03	0.73	0.73	0.52
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	54.01	2.42	1.10	0.66	1.10
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	49.66	3.93	0.56	0.84	1.12
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	39.81	3.33	0.37	0.56	1.30
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	56.15	4.55	0.27	0.00	1.34
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	51.56	4.59	1.07	0.92	1.68
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	37.18	3.37	0.91	1.42	1.68
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	46.90	4.07	1.08	1.36	1.08
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	48.85	2.21	0.55	0.00	0.74
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	54.61	3.07	1.54	1.54	1.10
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	53.55	3.97	0.00	0.99	1.98
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	48.81	2.11	1.45	0.26	0.79
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	50.24	4.64	1.41	1.01	1.01
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	89.21	3.05	1.27	2.03	1.27
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	36.23	3.58	0.20	1.19	1.00
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	44.99	1.69	0.46	0.31	1.08
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	39.48	2.86	0.00	1.02	1.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	52.57	1.25	0.31	0.31	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	42.67	3.96	0.85	0.00	1.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	30.44	0.92	0.46	0.46	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	34.65	0.00	2.47	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	50.67	1.55	0.39	0.77	3.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	57.76	4.81	1.60	1.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	22.60	3.48	0.00	3.48	3.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	51.10	2.60	0.98	0.33	1.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	49.42	2.06	0.00	0.41	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	36.65	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	38.59	2.52	0.56	0.84	1.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	43.80	2.29	0.33	0.65	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	38.59	1.68	0.84	0.84	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	41.99	0.64	1.91	0.00	1.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	49.25	1.70	0.34	0.34	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	50.12	0.00	4.18	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	45.24	2.86	0.57	1.15	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	41.73	0.30	1.78	0.00	0.89
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	44.05	5.08	1.69	0.00	3.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	51.36	2.90	0.83	0.41	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	39.81	2.07	0.92	0.46	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	63.22	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	48.82	1.54	0.00	1.15	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	48.24	1.63	0.98	0.98	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	52.84	0.67	0.67	1.34	0.67
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	59.72	0.77	1.16	0.77	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	52.72	0.68	2.40	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	79.51	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	58.98	0.94	1.42	0.94	0.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	59.75	1.21	2.41	1.21	1.21
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	69.18	4.07	1.02	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	48.66	1.60	1.60	0.40	0.80
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	71.54	4.93	0.99	1.48	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	50.76	1.18	0.00	1.18	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	67.10	4.08	1.75	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	57.49	1.32	0.88	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	47.47	0.00	0.85	0.00	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	48.95	0.60	0.60	1.19	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	49.98	0.49	1.94	0.49	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	31.96	4.57	1.14	2.28	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	42.83	5.82	0.83	1.66	2.49
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	34.86	1.12	1.12	1.12	1.12
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	75.80	4.12	1.27	1.59	3.49
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	66.84	4.60	2.09	1.67	3.76
Hep-2 cells mock treated, biol_rep1	11898-125E8	43.86	2.09	1.16	0.58	0.58
Hep-2 cells mock treated, biol_rep2	11899-125E9	37.14	1.52	0.84	0.00	1.01
Hep-2 cells mock treated, biol_rep3	11900-125F1	35.26	1.59	0.68	0.91	1.14
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	48.10	2.19	0.87	0.98	0.55
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	34.60	2.15	0.43	0.21	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	31.22	1.51	1.29	0.22	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	44.46	2.37	0.87	0.75	1.12
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	39.11	2.92	1.37	0.34	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	35.88	1.60	0.96	0.64	0.64
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	32.46	1.68	2.80	0.00	0.56
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	34.19	1.30	2.60	0.43	0.43
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	55.52	0.00	5.29	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	38.45	3.53	1.76	0.35	0.71
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	45.04	2.18	2.18	1.45	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	38.29	2.27	0.70	0.00	1.05
Hepatocyte, donor1	11523-119I2	49.63	1.21	0.00	1.21	0.00
Hepatocyte, donor2	11603-120I1	88.34	2.15	0.00	1.08	1.08
Hepatocyte, donor3	11684-122I1	58.29	3.68	0.61	0.00	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	28.72	1.31	0.65	0.65	0.65
Intestinal epithelial cells (polarized), donor1	11246-116E4	38.10	1.05	0.70	0.17	0.00
Iris Pigment Epithelial Cells, donor1	11530-119I9	24.29	2.47	1.78	0.96	0.14
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	15.92	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	33.38	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	27.08	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	12.46	1.38	0.00	1.38	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	27.53	2.50	0.00	5.01	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	47.47	0.00	11.87	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	28.19	0.00	0.00	0.00	2.56
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	22.85	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	30.86	0.00	0.00	0.00	1.62
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	10.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	21.78	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	23.82	0.00	1.32	2.65	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	18.85	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	20.95	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	25.82	1.26	0.63	0.63	0.63
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	15.47	1.55	0.00	1.55	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	23.26	2.58	0.65	0.65	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	16.10	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	11.95	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	26.89	0.00	0.81	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	20.99	1.68	0.00	0.42	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	14.37	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	22.50	0.80	0.80	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	26.78	0.00	0.92	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	45.24	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	21.24	2.83	0.00	0.47	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	16.33	0.91	0.00	0.91	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	44.23	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	22.60	3.23	1.08	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	24.14	2.54	1.27	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	25.51	0.00	1.91	0.64	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	34.63	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	27.13	1.43	0.00	0.00	0.71
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	33.18	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	20.85	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	20.37	1.54	0.93	0.00	0.31
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	36.88	0.00	1.76	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	28.29	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	18.78	0.70	0.00	1.39	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	30.98	0.00	0.00	2.21	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	25.94	3.24	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	32.26	0.00	0.87	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	33.75	2.25	2.25	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	34.85	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	35.20	2.13	1.07	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	36.02	1.39	0.00	1.39	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	22.80	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	33.14	0.92	0.92	0.92	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	21.18	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	37.25	6.21	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	44.41	2.11	1.06	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	35.50	2.04	0.65	0.49	0.65
Keratinocyte - epidermal, donor2	11349-117G8	18.15	0.59	0.00	1.17	0.00
Keratinocyte - epidermal, donor3	11421-118F8	27.92	1.33	0.57	0.19	0.47
Keratinocyte - oral, donor1	11251-116E9	43.93	1.59	0.57	0.34	0.57
Keratocytes, donor1	11527-119I6	30.26	2.75	1.03	0.00	0.00
Keratocytes, donor2	11607-120I5	24.61	1.17	2.34	1.17	0.00
Keratocytes, donor3	11688-122I5	47.42	1.78	0.00	0.00	0.59
Krukenberg tumor cell line:HSKTC	10687-109F3	32.97	2.20	2.20	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	22.65	2.16	2.16	3.24	1.08
Lens Epithelial Cells, donor2	11609-120I7	25.03	1.38	0.69	0.35	0.35
Lens Epithelial Cells, donor3	11690-122I7	27.25	0.91	1.92	1.01	0.71
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	32.73	0.95	0.59	0.36	0.24
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	38.79	1.12	0.28	0.28	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	40.14	1.73	0.79	0.47	0.16
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	27.42	1.08	0.54	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	32.78	0.95	0.63	0.32	0.63
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	35.58	0.75	1.08	0.32	0.11
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	22.57	0.82	0.41	0.41	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	38.68	1.26	0.76	1.52	0.25
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	34.62	0.99	0.84	0.56	0.42
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	23.73	0.00	0.40	0.79	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	35.67	0.39	0.78	0.39	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	33.14	0.37	0.19	0.19	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	25.09	0.00	0.70	0.35	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	32.68	0.95	0.24	0.48	0.95
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	37.77	1.37	0.55	0.41	0.41
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	22.48	0.92	0.62	0.31	0.62
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	37.72	0.94	0.94	0.62	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	37.51	2.20	1.28	1.28	0.18
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	26.33	1.32	0.00	0.66	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	44.22	1.76	0.59	0.59	0.29
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	43.06	2.24	0.75	0.25	0.50
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	28.61	0.48	0.97	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	30.70	1.35	0.54	0.54	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	37.09	1.06	1.36	0.15	0.15
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	28.51	2.07	0.52	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	39.16	2.09	1.05	0.21	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	34.44	1.65	0.75	0.30	0.30
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	26.83	0.69	0.00	0.00	0.69
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	33.87	1.13	0.75	0.75	0.38
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	45.27	1.27	0.95	0.95	0.32
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	26.17	0.97	1.94	0.97	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	30.10	2.32	0.99	0.99	0.66
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	40.26	1.86	0.74	0.37	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	23.32	0.74	0.37	0.37	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	28.66	1.73	0.00	0.25	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	38.77	0.82	0.82	0.41	0.96
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	25.73	0.00	1.29	0.32	0.64
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	38.04	1.52	0.61	0.30	0.91
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	34.15	0.42	0.56	1.12	0.42
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	29.87	0.71	0.36	0.36	0.36
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	36.36	1.94	0.48	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	38.44	0.93	0.16	0.31	0.78
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	30.44	0.00	0.36	0.36	0.36
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	30.38	0.00	0.33	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	41.43	2.12	0.71	0.71	0.24
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	36.63	2.10	0.37	0.37	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	40.47	3.07	0.51	1.02	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	28.05	1.19	0.90	0.00	0.60
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	115.57	6.80	4.53	4.53	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	83.62	3.07	3.07	0.77	0.77
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	82.39	3.71	0.74	0.74	1.48
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	93.93	2.12	2.54	1.69	1.27
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	104.09	4.22	1.41	2.11	1.41
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	88.73	0.00	2.80	0.93	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	82.96	0.52	0.52	0.52	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	83.26	3.57	3.57	1.19	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	97.26	2.04	1.58	1.36	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	66.31	0.87	0.87	0.58	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	75.63	1.35	2.25	0.45	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	110.15	3.66	1.49	1.90	0.81
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	87.30	1.54	2.57	1.54	1.03
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	84.69	1.76	1.41	2.12	1.41
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	99.95	1.33	1.33	2.00	1.33
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	77.43	2.04	2.55	1.02	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	82.44	2.13	1.60	1.33	0.53
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	91.26	3.59	0.76	1.32	0.19
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	85.29	4.91	1.84	1.84	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	96.22	0.82	0.82	2.45	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	76.22	1.67	1.25	1.46	1.25
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	70.07	1.68	1.40	1.96	0.28
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	97.88	4.12	1.03	3.09	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	87.96	1.16	1.45	2.03	0.87
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	63.97	1.49	1.79	0.90	1.20
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	78.56	3.32	2.77	1.11	2.77
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	104.63	2.47	0.35	1.41	2.47
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	74.12	1.48	1.84	0.37	0.37
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	75.98	2.30	2.30	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	102.46	3.84	1.92	1.54	1.15
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	82.66	1.70	2.83	0.57	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	72.20	3.28	1.64	3.28	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	97.61	4.07	0.45	2.26	0.45
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	79.71	1.44	0.00	0.72	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	104.57	5.23	0.00	2.99	2.99
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	107.39	2.60	1.49	1.86	0.37
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	84.43	1.29	1.29	1.29	0.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	107.89	3.43	0.86	1.71	1.71
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	115.61	2.33	2.33	0.67	1.67
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	88.08	4.22	2.41	3.02	0.60
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	91.72	6.40	2.13	2.13	2.84
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	96.93	3.78	1.72	0.69	1.03
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	82.12	3.22	1.61	2.15	1.07
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	74.74	5.39	3.37	1.35	2.02
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	102.23	2.59	0.37	1.11	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	104.66	2.33	2.33	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	108.95	3.17	1.06	4.23	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	108.84	3.60	1.60	2.40	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	81.41	1.45	1.45	0.73	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	101.18	6.13	1.53	1.53	0.77
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	112.96	2.47	2.96	3.45	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	95.98	1.88	3.76	0.94	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	102.58	3.02	1.51	0.00	1.51
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	101.39	3.15	1.80	3.15	1.80
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	60.24	1.72	1.72	5.16	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	86.40	4.01	1.78	1.34	0.89
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	91.89	2.35	1.56	1.56	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	71.91	1.32	3.30	1.32	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	98.08	3.11	1.04	2.08	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	121.64	2.63	3.06	0.44	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	64.30	1.68	1.68	0.56	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	80.38	2.21	0.88	2.21	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	87.17	1.54	1.93	0.39	0.39
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	69.37	1.52	1.52	0.51	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	74.02	2.40	1.92	1.44	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	91.83	1.59	0.00	1.59	0.40
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	62.59	1.22	3.04	1.22	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	73.32	0.69	2.08	2.77	0.69
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	96.14	0.76	1.52	0.76	0.38
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	73.33	1.03	3.10	3.10	1.03
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	85.26	3.63	2.42	0.60	0.60
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	74.47	1.27	0.95	2.22	0.63
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	85.29	3.20	1.07	1.60	0.53
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	101.72	2.30	5.17	1.72	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	89.48	1.54	2.06	2.57	0.51
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	84.88	4.24	4.24	0.71	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	100.45	1.70	1.70	2.27	0.57
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	114.82	2.08	1.66	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	80.65	4.70	2.35	0.00	0.78
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	99.38	2.92	2.51	1.67	0.84
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	130.56	1.86	1.86	0.93	0.46
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	82.96	0.00	3.35	2.68	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	97.30	2.67	3.74	1.07	1.07
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	114.76	4.45	2.02	3.23	0.81
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	100.95	3.67	1.84	0.92	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	98.69	0.89	0.00	1.78	0.89
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	115.68	3.42	2.28	2.28	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	78.99	3.83	5.37	2.30	0.77
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	93.57	2.19	1.09	0.55	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	92.65	1.34	0.89	1.34	2.23
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	110.22	3.64	1.56	1.30	0.78
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	109.41	2.65	1.33	3.98	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	124.72	6.24	0.00	6.24	0.00
Macrophage - monocyte derived, donor1	11232-116C8	40.11	1.14	0.46	0.68	0.23
Macrophage - monocyte derived, donor2	11313-117C8	40.00	3.67	0.18	1.65	0.73
Macrophage - monocyte derived, donor3	11389-118C3	45.35	2.10	0.52	0.26	1.31
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	32.39	4.78	0.53	0.00	1.59
Mallassez-derived cells, donor2	11929-125I3	29.63	0.95	0.48	0.32	0.32
Mallassez-derived cells, donor3	11930-125I4	24.32	1.39	0.42	0.83	0.56
Mammary Epithelial Cell, donor1	11273-116H4	25.21	1.10	0.40	0.40	0.10
Mammary Epithelial Cell, donor2	11350-117G9	22.87	1.45	0.58	0.58	0.29
Mammary Epithelial Cell, donor3	11422-118F9	20.45	1.50	0.50	1.00	0.25
Mast cell - stimulated, donor1	11487-119E2	4.75	0.68	1.36	0.00	0.00
Mast cell, donor1	11563-120D6	36.34	2.81	0.65	0.32	0.54
Mast cell, donor2	11565-120D8	64.78	0.89	0.00	0.00	0.30
Mast cell, donor3	11566-120D9	78.79	1.58	0.23	0.23	0.00
Mast cell, donor4	11567-120E1	94.50	0.89	0.35	0.35	0.18
Mast cell, expanded and stimulated, donor5	11940-126A5	48.02	1.66	0.44	0.67	0.11
Mast cell, expanded and stimulated, donor8	11942-126A7	48.45	0.00	1.17	2.92	0.00
Mast cell, expanded, donor5	11939-126A4	43.71	1.72	1.03	0.80	0.11
Mast cell, expanded, donor8	11941-126A6	93.22	5.36	1.34	1.34	0.67
Melanocyte - dark, donor1	11502-119F8	57.01	1.59	1.49	0.70	0.20
Melanocyte - dark, donor2	11582-120F7	46.38	3.11	0.00	0.35	2.08
Melanocyte - dark, donor3	11663-122F7	56.65	5.07	1.30	1.30	1.67
Melanocyte - light, donor1	11274-116H5	49.84	3.76	0.71	0.94	0.71
Melanocyte - light, donor2	11351-117H1	42.31	3.41	0.68	0.68	0.68
Melanocyte - light, donor3	11423-118G1	35.56	1.73	2.60	1.73	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	54.46	3.12	2.50	0.83	1.15
Melanocyte, donor2 (MC+2)	12739-135I3	45.18	2.96	1.61	2.42	0.81
Melanocyte, donor3 (MC+3)	12837-137B2	49.29	2.68	1.61	0.80	1.61
Meningeal Cells, donor1	11493-119E8	25.68	4.22	1.36	1.49	1.61
Meningeal Cells, donor2	11573-120E7	17.17	3.08	1.76	2.20	2.64
Meningeal Cells, donor3	11654-122E7	34.72	3.75	1.30	1.22	1.96
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	32.22	1.43	1.14	0.86	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	28.18	1.71	1.31	0.91	0.00
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	131.42	18.40	1.31	5.26	2.63
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	47.09	1.31	0.00	2.62	1.31
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	54.54	0.72	1.44	0.72	0.72
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	32.40	1.48	1.69	0.85	1.27
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	27.65	1.01	2.01	3.02	1.01
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	34.94	1.54	0.44	0.22	0.22
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	36.53	2.19	0.73	1.46	0.73
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	40.72	2.86	1.84	0.41	0.20
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	44.32	4.57	2.22	1.94	0.97
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	83.27	5.20	2.23	1.49	1.12
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	46.97	1.84	0.26	0.26	0.26
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	82.20	10.39	2.08	2.67	5.04
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	81.74	4.67	2.34	4.67	2.34
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	49.31	1.92	1.92	1.28	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	41.12	3.19	1.06	0.00	0.71
Mesenchymal stem cells - hepatic, donor0	11218-116B3	41.91	0.31	0.94	0.00	0.94
Mesenchymal stem cells - umbilical, donor0	11214-116A8	37.74	6.53	0.73	0.73	2.18
Mesothelial Cells, donor1	11247-116E5	54.63	3.18	1.06	1.33	0.27
Mesothelial Cells, donor2	12156-128G5	43.04	5.00	3.00	1.00	0.50
Mesothelial Cells, donor3	11402-118D7	37.79	2.17	2.75	1.52	0.79
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	90.47	6.75	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	46.05	2.71	0.74	0.25	1.72
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	61.84	4.71	0.88	0.88	1.47
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	44.94	3.46	3.46	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	34.09	4.65	1.24	1.24	0.31
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	49.16	3.11	1.04	1.66	0.41
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	55.59	6.95	2.32	2.32	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	47.55	3.50	1.50	0.50	1.25
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	60.51	3.72	1.86	1.40	0.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	175.20	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	50.60	3.66	0.61	1.02	0.81
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	57.41	2.38	1.58	0.40	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	68.41	0.00	0.00	0.00	8.55
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	32.74	4.42	0.00	0.88	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	56.99	4.94	0.76	0.76	0.38
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	47.37	5.26	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	38.41	2.12	0.21	0.64	1.06
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	50.65	1.84	0.92	0.00	0.92
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	31.59	2.98	0.60	0.89	0.30
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	46.95	6.71	3.35	0.00	3.35
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	67.90	0.00	33.95	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	32.12	3.26	0.25	0.00	1.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	38.50	1.19	0.71	0.48	0.48
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	23.77	1.66	0.55	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	31.08	2.99	0.23	0.69	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	40.17	2.10	0.42	0.42	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	29.76	2.65	0.82	0.20	0.41
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	29.82	1.07	0.43	0.21	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	36.23	3.56	0.67	0.89	0.89
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	103.18	0.00	0.00	0.00	10.32
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	23.00	2.63	0.00	0.22	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	38.53	1.01	0.51	1.52	1.01
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	31.48	3.31	0.00	0.00	1.66
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	25.28	1.90	0.27	0.82	1.09
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	32.35	2.65	0.59	1.18	0.29
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	33.80	2.18	0.00	0.00	2.18
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	39.89	2.88	0.96	0.96	0.96
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	40.42	3.60	0.80	1.60	1.20
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	38.39	6.86	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	28.53	0.50	0.00	1.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	26.95	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	26.50	6.12	4.08	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	30.65	0.88	1.31	0.88	1.31
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	43.04	8.83	0.00	1.10	3.31
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	40.34	4.48	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	30.49	1.98	0.99	0.25	1.24
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	29.92	3.48	0.00	0.00	0.70
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	30.94	8.84	2.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	28.38	2.74	0.00	0.00	1.03
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	32.38	2.63	0.88	0.00	0.44
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	27.70	3.55	0.71	0.36	1.78
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	40.12	1.96	0.56	0.28	1.40
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	28.68	3.74	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	26.22	2.91	0.58	0.58	1.17
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	27.75	3.62	0.30	0.60	1.21
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	36.31	2.92	0.00	0.42	1.67
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	50.53	7.22	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	19.39	2.77	0.00	0.00	0.92
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	35.29	2.28	0.00	2.28	0.57
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	27.64	2.63	0.28	0.28	0.14
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	32.91	3.63	0.26	0.26	1.30
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	41.61	3.86	0.00	0.43	1.29
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	36.21	2.54	0.64	0.00	1.27
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	27.76	2.14	0.00	0.27	0.27
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	44.00	2.69	0.60	0.90	1.80
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	21.61	1.84	0.00	0.28	0.42
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	39.18	3.82	0.00	0.00	1.59
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	42.90	5.31	1.33	0.44	1.33
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	29.20	5.69	0.00	0.38	0.38
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	27.84	2.56	0.85	0.28	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	40.56	4.92	0.49	0.25	1.47
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	32.58	3.91	0.65	0.00	1.96
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	34.70	3.82	0.29	0.00	0.29
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	54.49	5.48	0.58	0.86	2.31
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	41.21	4.53	0.00	0.82	0.41
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	36.93	5.36	0.00	0.30	0.60
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	37.67	3.77	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	33.86	7.13	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	36.80	2.96	0.33	0.33	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	34.71	0.00	1.05	1.05	1.05
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	37.76	0.99	0.20	0.20	0.40
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	48.43	0.93	1.86	0.93	0.93
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	28.54	2.25	1.13	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	45.28	2.66	0.27	0.80	0.27
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	27.94	1.58	0.34	0.45	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	36.84	1.47	0.74	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	33.71	1.83	0.37	0.73	0.37
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	40.45	1.56	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	12.29	1.60	1.07	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	15.46	0.00	0.00	3.86	3.86
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	34.34	2.02	2.02	1.01	1.01
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	35.42	2.11	0.84	0.00	0.42
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	8.17	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	8.27	1.91	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	7.29	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	12.08	0.00	1.51	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	34.26	0.00	5.71	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	32.62	0.00	0.00	3.26	3.26
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	14.26	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	25.10	25.10	12.55	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	24.34	1.94	2.80	2.37	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	22.47	1.57	1.57	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	26.03	0.00	6.01	2.67	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	20.45	1.67	1.25	0.83	0.83
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	24.72	0.95	0.76	0.76	0.57
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	30.32	1.60	6.38	1.60	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	19.04	0.68	0.00	0.68	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	12.86	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	24.69	2.51	0.84	3.35	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	25.57	1.86	1.39	0.70	0.46
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	26.21	1.89	1.08	1.08	1.35
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	32.38	2.52	1.68	1.47	1.05
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	11.13	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	35.74	2.98	2.48	0.99	1.49
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	38.98	1.89	2.71	1.35	1.08
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	30.60	1.13	1.81	1.13	1.13
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	23.68	1.96	1.96	1.96	1.47
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	40.83	3.46	1.46	1.82	1.64
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	45.62	2.12	3.18	3.71	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	39.62	2.40	1.80	3.00	1.20
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	54.81	2.30	1.97	0.66	1.97
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	34.80	3.90	2.11	2.28	2.11
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	47.62	4.23	2.12	1.94	1.41
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	40.08	2.11	1.41	0.70	0.70
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	52.41	4.14	1.84	0.00	1.84
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	45.63	5.14	2.25	1.93	1.61
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	37.59	0.69	0.34	0.69	1.03
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	10.11	0.00	0.00	0.00	2.53
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	38.54	3.12	1.34	0.89	2.01
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	35.14	2.54	2.54	0.85	0.85
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	43.44	2.85	0.95	0.95	1.42
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	38.20	3.00	1.29	1.72	1.29
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	9.03	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	25.32	2.00	3.33	2.00	0.67
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	36.52	1.35	2.25	2.25	1.80
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	22.62	1.19	0.40	2.78	0.40
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	34.36	0.00	0.93	2.79	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	50.32	3.03	4.16	3.41	1.89
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	22.81	2.61	1.30	1.30	0.65
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	23.10	2.61	2.61	0.87	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	30.76	4.52	1.81	0.45	0.90
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	23.81	1.76	1.76	0.00	1.76
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	41.89	2.66	1.99	2.66	2.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	46.63	1.49	3.47	1.98	3.97
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	28.33	3.06	1.91	2.30	0.77
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	74.40	3.93	3.63	1.81	0.60
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	27.85	1.33	1.33	1.99	0.44
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	27.11	0.68	3.39	1.36	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	15.33	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	41.46	3.05	3.66	6.10	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	21.72	2.52	3.15	2.20	0.63
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	30.57	2.12	0.91	0.91	2.72
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	28.48	0.79	3.96	0.79	1.58
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	30.61	1.13	2.27	0.00	1.13
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	35.41	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	46.09	2.11	2.11	1.12	0.99
Myoblast, donor2	11322-117D8	46.41	2.11	1.15	1.73	0.38
Myoblast, donor3	11398-118D3	25.06	4.88	0.34	1.68	2.35
NK T cell leukemia cell line:KHYG-1	10777-110G3	24.08	1.75	1.02	0.29	0.29
Natural Killer Cells, donor1	11230-116C6	25.22	0.62	0.31	0.00	0.00
Natural Killer Cells, donor2	11311-117C6	20.51	0.30	0.00	0.60	0.00
Natural Killer Cells, donor3	11387-118C1	25.77	1.29	0.37	0.18	0.18
Neural stem cells, donor1	11275-116H6	18.87	1.45	1.09	0.36	0.00
Neural stem cells, donor2	11352-117H2	15.41	0.00	0.00	0.00	0.00
Neurons, donor1	11494-119E9	34.14	4.55	0.00	0.00	1.14
Neurons, donor2	11574-120E8	38.09	3.74	0.44	0.66	0.44
Neurons, donor3	11655-122E8	17.27	0.82	0.00	1.64	0.00
Neutrophils, donor1	11233-116C9	49.18	3.71	0.00	0.00	1.86
Neutrophils, donor2	11314-117C9	57.98	2.90	0.00	0.00	2.90
Neutrophils, donor3	11390-118C4	70.25	6.11	0.00	0.00	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	75.40	2.37	1.78	1.31	0.71
Nucleus Pulposus Cell, donor2	11409-118E5	65.77	2.28	0.65	0.98	0.98
Nucleus Pulposus Cell, donor3	11462-119B4	35.30	1.60	0.80	1.00	0.00
Olfactory epithelial cells, donor1	11933-125I7	34.28	1.10	0.83	1.51	0.00
Olfactory epithelial cells, donor2	11934-125I8	37.20	1.45	1.74	0.87	0.14
Olfactory epithelial cells, donor3	11935-125I9	33.48	1.02	1.25	1.25	0.34
Olfactory epithelial cells, donor4	11936-126A1	41.69	0.88	2.53	1.17	0.10
Oligodendrocyte - precursors, donor1	11496-119F2	48.75	3.61	1.20	1.20	0.00
Osteoblast - differentiated, donor1	11276-116H7	48.71	2.55	2.55	1.28	1.06
Osteoblast - differentiated, donor2	11353-117H3	107.45	9.14	5.72	2.29	6.86
Osteoblast - differentiated, donor3	11425-118G3	58.97	0.00	0.00	0.00	1.24
Osteoblast, donor1	11277-116H8	30.10	2.15	0.98	0.78	0.59
Osteoblast, donor2	11354-117H4	28.09	0.00	2.11	0.70	0.00
Osteoblast, donor3	11426-118G4	28.08	1.24	1.78	1.24	0.71
Pancreatic stromal cells, donor1	11249-116E7	41.36	2.11	0.76	0.59	0.34
Pericytes, donor1	11491-119E6	44.17	3.56	3.23	2.34	2.34
Pericytes, donor2	11571-120E5	46.18	4.53	1.81	1.81	3.85
Pericytes, donor3	11652-122E5	34.38	2.03	2.24	1.22	0.61
Perineurial Cells, donor1	11499-119F5	29.95	1.47	1.24	1.36	1.24
Perineurial Cells, donor2	11579-120F4	55.30	6.72	0.64	0.09	1.47
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	29.64	2.23	0.00	0.00	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	30.61	0.98	0.00	0.24	0.00
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	32.10	1.81	0.13	0.00	0.26
Placental Epithelial Cells, donor1	11278-116H9	75.82	2.39	0.72	0.72	0.96
Placental Epithelial Cells, donor2	11355-117H5	54.34	3.33	2.22	2.22	0.00
Placental Epithelial Cells, donor3	11427-118G5	45.74	1.18	0.98	0.59	0.39
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	75.63	2.53	2.53	1.58	0.32
Preadipocyte - breast, donor1	11467-119B9	60.59	1.69	2.25	1.31	0.19
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	30.67	0.91	1.04	1.04	0.26
Preadipocyte - breast, donor2	11328-117E5	61.69	2.70	0.68	3.60	0.68
Preadipocyte - omental, donor1	11468-119C1	75.66	4.16	3.41	3.09	0.64
Preadipocyte - omental, donor2	11329-117E6	55.87	4.36	3.93	2.62	0.00
Preadipocyte - omental, donor3	11403-118D8	43.26	2.58	2.29	2.44	1.29
Preadipocyte - perirenal, donor1	11469-119C2	53.15	4.92	0.98	2.95	1.97
Preadipocyte - subcutaneous, donor1	11279-116I1	38.70	3.07	0.92	0.61	1.23
Preadipocyte - subcutaneous, donor2	11356-117H6	45.15	3.72	0.89	0.89	0.35
Preadipocyte - subcutaneous, donor3	11428-118G6	43.76	3.75	0.51	1.19	1.36
Preadipocyte - visceral, donor1	11280-116I2	37.17	2.51	1.30	0.84	0.28
Preadipocyte - visceral, donor2	11357-117H7	35.89	4.14	1.38	1.38	0.00
Preadipocyte - visceral, donor3	11429-118G7	35.11	2.19	1.04	1.57	0.21
Prostate Epithelial Cells (polarized), donor1	11253-116F2	45.41	1.96	0.75	0.15	0.30
Prostate Epithelial Cells, donor2	11331-117E8	28.03	1.22	1.90	1.22	0.41
Prostate Epithelial Cells, donor3	11404-118D9	19.66	0.73	0.06	0.06	0.06
Prostate Stromal Cells, donor1	11254-116F3	42.03	3.53	0.91	0.91	0.46
Prostate Stromal Cells, donor2	11332-117E9	47.87	2.87	0.90	0.54	1.61
Prostate Stromal Cells, donor3	11405-118E1	66.84	5.21	1.36	1.04	2.40
Renal Cortical Epithelial Cells, donor1	11516-119H4	27.01	0.36	1.82	0.36	0.73
Renal Cortical Epithelial Cells, donor2	11596-120H3	32.99	0.35	0.62	0.07	0.07
Renal Epithelial Cells, donor1	11517-119H5	49.71	2.03	0.51	1.52	0.51
Renal Epithelial Cells, donor2	11597-120H4	33.43	1.42	1.42	0.71	0.71
Renal Epithelial Cells, donor3	11678-122H4	39.17	0.95	0.74	0.53	0.21
Renal Glomerular Endothelial Cells, donor1	11514-119H2	24.51	1.36	0.00	1.36	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	23.58	0.81	1.89	1.08	0.54
Renal Glomerular Endothelial Cells, donor3	11675-122H1	30.42	0.44	1.55	0.89	0.67
Renal Glomerular Endothelial Cells, donor4	11783-124B1	57.23	4.66	0.00	2.66	0.00
Renal Mesangial Cells, donor1	11518-119H6	36.09	2.64	1.32	1.10	0.44
Renal Mesangial Cells, donor2	11598-120H5	41.38	0.63	1.88	0.63	0.00
Renal Mesangial Cells, donor3	11679-122H5	39.39	3.05	0.83	1.39	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	28.18	1.61	1.07	0.27	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	33.31	1.27	0.84	0.42	0.42
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	34.13	0.58	0.77	0.96	0.58
Retinal Pigment Epithelial Cells, donor0	11215-116A9	29.04	0.78	1.81	0.00	0.26
Retinal Pigment Epithelial Cells, donor1	11528-119I7	24.16	1.42	0.85	1.14	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	28.82	1.03	1.03	1.03	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	30.11	0.50	0.75	0.50	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	70.16	3.74	0.53	0.53	0.27
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	20.55	2.68	0.00	0.89	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	17.61	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	16.24	0.58	0.58	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	14.43	0.91	0.39	0.26	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	18.87	1.89	0.60	0.50	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	24.76	3.23	0.33	0.45	0.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	20.34	1.36	0.87	0.12	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	22.84	2.10	0.47	0.82	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	22.65	0.92	0.46	0.69	0.92
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	17.39	1.64	0.55	0.27	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	18.15	1.36	0.61	0.91	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	21.86	3.58	0.18	0.54	0.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	21.23	1.43	0.43	1.29	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	22.97	1.93	0.43	0.86	0.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	22.57	2.21	1.55	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	17.78	2.49	0.19	0.57	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	20.12	2.33	0.19	0.75	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	21.23	1.88	0.56	0.00	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	16.19	2.26	0.80	0.40	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	24.72	1.46	0.68	0.68	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	19.48	2.29	0.95	0.19	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	18.05	2.24	0.64	1.07	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	22.70	2.52	0.56	0.00	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	18.12	2.39	0.85	0.17	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	15.13	0.91	0.36	1.28	0.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	20.23	1.84	0.98	0.25	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	21.63	1.48	0.67	1.07	0.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	20.99	1.89	0.71	0.71	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	21.43	1.39	1.19	0.79	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	18.94	2.81	0.94	0.70	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	20.53	1.45	0.83	0.21	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	19.91	0.88	1.33	0.00	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	18.17	2.51	0.42	0.00	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	19.51	1.48	0.54	0.54	0.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	17.03	2.55	0.34	0.85	0.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	15.23	1.93	1.35	0.77	0.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	19.77	1.89	0.69	0.34	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	18.93	2.19	0.69	0.69	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	23.15	1.81	0.99	0.66	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	19.94	1.87	0.68	0.34	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	24.56	2.52	0.59	0.74	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	27.72	1.33	0.53	0.80	0.80
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	25.58	2.35	0.41	0.41	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	24.76	2.86	0.95	1.67	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	25.80	3.02	0.60	0.60	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	25.52	2.07	0.57	0.94	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	34.59	3.49	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	25.99	2.72	1.21	0.30	0.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	27.78	2.94	0.61	0.73	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	26.64	3.06	0.44	0.58	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	23.73	4.26	0.61	0.00	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	29.54	2.41	0.00	0.00	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	52.93	4.75	0.68	1.36	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	43.13	3.59	0.30	0.30	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	32.82	3.66	0.71	0.59	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	32.23	4.91	0.43	0.85	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	27.04	1.20	0.00	1.80	0.00
Schwann Cells, donor1	11498-119F4	39.31	3.95	0.75	1.50	0.94
Schwann Cells, donor2	11578-120F3	30.62	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	43.16	2.85	1.53	0.44	1.10
Sebocyte, donor1	11220-116B5	27.39	0.00	0.00	1.64	0.55
Sebocyte, donor2	11301-117B5	31.25	0.00	0.00	0.00	0.46
Sebocyte, donor3	11378-118B1	44.93	1.65	0.82	0.21	1.24
Sertoli Cells, donor1	11255-116F4	44.73	3.31	1.66	0.00	3.31
Sertoli Cells, donor2	11333-117F1	36.72	2.82	2.82	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	28.59	1.06	1.06	0.62	0.26
Skeletal Muscle Cells, donor2	11358-117H8	18.79	0.72	0.00	0.72	0.00
Skeletal Muscle Cells, donor3	11430-118G8	39.29	1.67	0.00	0.84	0.84
Skeletal Muscle Cells, donor4	11451-119A2	25.76	1.26	0.47	0.31	0.16
Skeletal Muscle Cells, donor5	11455-119A6	21.26	0.89	0.74	0.00	0.00
Skeletal Muscle Cells, donor6	11459-119B1	16.78	1.08	0.62	0.92	0.15
Skeletal Muscle Satellite Cells, donor1	11240-116D7	39.31	1.89	0.25	1.13	0.25
Skeletal Muscle Satellite Cells, donor2	11321-117D7	37.10	1.28	0.71	0.57	0.29
Skeletal Muscle Satellite Cells, donor3	11397-118D2	25.60	2.08	1.09	0.50	0.40
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	26.54	1.60	0.51	0.34	0.17
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	20.27	1.45	1.45	0.72	0.72
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	19.26	1.38	1.38	0.96	0.00
Skin - palm, donor1	10286-104F7	29.55	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	29.70	1.44	1.01	1.01	0.43
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	22.90	0.00	1.64	0.00	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	27.91	1.82	1.04	1.04	0.13
Small Airway Epithelial Cells, donor1	11256-116F5	21.82	0.97	0.70	0.56	0.14
Small Airway Epithelial Cells, donor2	11334-117F2	22.93	2.11	0.14	0.14	0.00
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	22.62	2.11	0.42	0.63	0.42
Small Airway Epithelial Cells, donor3	11406-118E2	25.33	1.35	0.22	0.15	0.15
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	52.15	2.47	2.16	1.54	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	36.91	1.11	3.56	0.67	0.44
Smooth Muscle Cells - Aortic, donor0	11210-116A4	35.27	1.18	2.35	1.18	2.94
Smooth Muscle Cells - Aortic, donor1	11283-116I5	35.14	1.55	0.66	0.44	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	35.83	1.97	4.33	1.58	0.79
Smooth Muscle Cells - Aortic, donor3	11432-118H1	42.49	2.32	0.77	2.32	0.77
Smooth Muscle Cells - Bladder, donor1	11519-119H7	77.06	3.00	0.00	3.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	33.40	1.46	1.06	1.20	0.53
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	56.74	4.43	1.99	0.44	0.66
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	32.14	1.28	1.15	1.54	0.51
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	22.79	3.58	1.30	0.33	1.63
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	21.85	2.36	0.89	0.89	1.18
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	34.88	3.13	1.57	1.71	1.42
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	37.09	3.25	1.63	1.30	0.49
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	46.27	3.04	1.22	0.61	1.22
Smooth Muscle Cells - Carotid, donor1	11285-116I7	42.18	2.53	0.51	1.77	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	18.36	12.24	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	20.98	0.95	2.38	0.48	0.48
Smooth Muscle Cells - Colonic, donor1	11239-116D6	29.20	2.80	0.44	0.44	0.44
Smooth Muscle Cells - Colonic, donor2	11320-117D6	24.54	1.94	0.86	0.65	0.65
Smooth Muscle Cells - Colonic, donor3	11396-118D1	26.34	2.83	1.26	0.52	0.73
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	39.44	2.32	1.86	0.93	0.62
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	36.65	2.16	2.16	1.08	2.16
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	28.39	3.59	0.90	1.20	0.60
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	30.04	3.41	1.71	1.02	0.68
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	51.12	2.91	0.63	0.79	0.47
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	44.79	1.91	2.31	2.11	0.50
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	65.76	3.41	1.14	1.14	1.37
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	32.00	1.81	0.00	1.81	0.60
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	31.79	2.38	0.53	0.26	1.59
Smooth Muscle Cells - Prostate, donor1	11257-116F6	33.82	3.73	1.20	1.07	0.27
Smooth Muscle Cells - Prostate, donor2	11335-117F3	47.33	3.26	1.25	1.13	1.00
Smooth Muscle Cells - Prostate, donor3	11465-119B7	44.90	4.06	1.78	0.51	2.28
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	48.85	1.66	1.06	1.06	0.60
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	41.26	3.00	0.00	0.00	0.75
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	19.38	1.29	2.58	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	51.62	1.86	2.79	2.33	0.47
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	60.08	2.02	4.04	2.02	1.01
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	41.37	2.51	0.94	0.94	0.63
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	35.40	1.18	2.65	0.59	0.59
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	32.24	2.00	0.75	0.92	0.58
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	45.31	1.40	2.34	0.00	0.93
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	23.31	1.01	0.58	0.72	0.29
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	27.03	2.04	1.27	0.25	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	17.86	1.69	0.94	0.38	0.19
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	26.83	1.82	1.40	0.98	0.14
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	46.08	2.43	0.92	1.01	0.50
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	52.86	0.48	0.95	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	19.57	1.22	0.49	0.49	0.49
Smooth Muscle Cells - Uterine, donor1	11258-116F7	36.46	1.77	1.33	0.88	0.66
Smooth Muscle Cells - Uterine, donor3	11466-119B8	37.74	1.76	0.59	0.00	0.29
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	70.94	3.50	1.94	1.94	1.17
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	46.28	2.12	1.59	1.06	0.79
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	39.80	1.12	0.37	0.37	0.37
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	68.27	5.39	2.87	2.16	0.36
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	45.42	1.14	1.14	1.14	0.57
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	29.15	0.79	2.76	0.39	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	49.27	1.78	0.51	0.25	0.51
Smooth muscle cells - airway, control, donor2	11967-126D5	55.51	2.00	0.40	0.00	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	51.83	2.51	1.67	0.84	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	48.59	2.75	1.38	0.92	0.92
Synoviocyte, donor1	11291-117A4	45.28	1.18	1.68	0.50	0.17
Synoviocyte, donor2	11368-117I9	70.91	2.68	0.84	1.34	1.51
Synoviocyte, donor3	11440-118H9	50.71	1.34	1.34	1.79	0.22
Trabecular Meshwork Cells, donor1	11532-120A2	33.95	0.71	0.71	0.00	1.43
Trabecular Meshwork Cells, donor2	11612-122A1	43.60	1.98	0.00	1.98	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	34.73	0.93	1.16	0.69	0.46
Tracheal Epithelial Cells, donor1	11292-117A5	14.70	0.93	0.14	0.07	0.07
Tracheal Epithelial Cells, donor2	11369-118A1	28.61	1.93	0.00	1.16	0.39
Tracheal Epithelial Cells, donor3	11441-118I1	17.18	0.57	0.00	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	69.26	2.21	1.35	0.86	0.62
Urethra, donor2	10319-105A4	34.17	1.80	5.40	0.00	0.00
Urothelial Cells, donor1	11520-119H8	26.83	1.06	0.53	0.27	0.00
Urothelial Cells, donor2	11600-120H7	30.04	1.20	0.40	0.40	0.00
Urothelial Cells, donor3	11681-122H7	27.50	0.69	0.46	1.15	0.92
Urothelial cells, donor0	11216-116B1	33.66	2.67	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	104.10	4.45	0.89	4.45	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	107.22	4.29	4.29	2.86	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	82.83	5.48	0.00	1.37	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	63.36	0.69	0.69	1.03	1.38
Whole blood (ribopure), donor090325, donation2	12177-128I8	69.14	2.32	2.91	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	66.64	3.12	2.08	2.08	1.04
Whole blood (ribopure), donor090612, donation2	12183-129A5	79.85	3.67	2.75	1.84	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	90.38	1.83	1.83	2.74	0.91
Wilms' tumor cell line:G-401	10809-111A8	20.72	1.23	0.62	0.37	0.37
Wilms' tumor cell line:HFWT	10597-108E3	28.16	0.88	2.64	0.88	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	17.60	0.56	0.28	0.00	0.00
achilles tendon, donor2	10292-104G4	28.93	0.00	2.07	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	17.85	0.25	0.25	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	19.04	0.46	0.46	0.23	0.46
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	19.59	1.19	0.24	0.00	0.59
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	31.29	1.36	0.54	0.00	0.27
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	25.86	1.12	2.25	0.84	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	60.70	2.54	2.75	2.11	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	18.78	0.27	0.27	0.82	0.27
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	13.22	0.00	1.32	0.44	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	30.22	0.82	2.86	3.27	0.82
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	20.19	1.94	3.11	3.49	0.78
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	16.74	0.92	0.37	0.18	0.18
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	31.20	7.80	0.00	11.70	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	30.91	0.93	1.39	1.86	0.46
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	30.55	1.81	1.29	0.26	0.26
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	18.12	0.29	0.88	0.88	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	17.66	0.00	0.93	0.46	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	25.91	2.88	0.41	0.41	0.82
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	23.64	1.53	0.61	0.31	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	23.47	2.99	0.00	0.00	1.71
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	22.75	0.91	0.30	0.61	0.30
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	31.05	3.61	0.72	0.48	1.68
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	16.48	0.89	0.22	0.67	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	10.67	2.33	0.00	0.33	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	27.87	1.86	1.86	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	26.37	2.64	0.38	0.75	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	20.06	2.18	0.87	0.87	0.44
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	15.00	1.87	3.75	1.87	0.00
adenocarcinoma cell line:IM95m	10796-110I4	31.79	1.88	0.94	0.24	0.00
adipose tissue, adult, pool1	10010-101C1	72.75	2.02	0.62	0.16	0.31
adipose, donor1	10184-103D4	58.05	0.59	0.00	0.59	0.00
adipose, donor2	10185-103D5	32.85	0.00	1.62	1.22	0.00
adipose, donor3	10186-103D6	25.05	0.82	1.09	0.54	0.54
adipose, donor4	10187-103D7	25.14	1.73	2.60	0.00	0.87
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	10.10	0.32	1.42	1.26	0.16
adrenal gland, adult, pool1	10081-102A9	47.29	7.28	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	27.48	1.60	0.40	0.53	0.13
alveolar cell carcinoma cell line:SW 1573	10708-109H6	22.51	2.14	1.07	1.07	0.36
amniotic membrane cells, donor1	12235-129G3	60.74	3.01	0.23	0.23	1.16
amniotic membrane cells, donor2	12236-129G4	69.99	3.72	3.04	1.01	0.68
amniotic membrane cells, donor3	12237-129G5	55.97	0.88	0.29	0.59	0.59
amygdala - adult, donor10196	10167-103B5	35.57	1.19	2.37	5.93	2.37
amygdala, adult, donor10252	10151-102I7	40.96	1.82	2.43	2.43	1.42
amygdala, newborn, donor10223	10360-105E9	48.42	3.55	2.58	2.58	0.97
anaplastic carcinoma cell line:8305C	10428-106D5	20.88	0.76	0.25	0.25	0.00
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	22.28	1.32	0.00	0.22	0.88
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	19.04	1.00	0.67	1.00	0.33
aorta, adult, pool1	10052-101G7	56.49	0.59	0.59	0.59	0.20
appendix, adult	10189-103D9	39.59	0.39	0.39	0.00	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	32.33	1.03	1.03	2.06	0.34
artery, adult	10190-103E1	36.68	2.72	1.36	2.72	1.36
astrocytoma cell line:TM-31	10425-106D2	33.03	1.45	0.87	1.74	0.14
b cell line:RPMI1788	10427-106D4	13.83	0.00	0.45	0.15	0.45
basal cell carcinoma cell line:TE 354.T	10702-109G9	32.18	0.55	3.33	1.39	0.28
bile duct carcinoma cell line:HuCCT1	10432-106D9	11.91	0.60	0.20	0.00	0.00
bile duct carcinoma cell line:TFK-1	10496-107C1	15.06	0.50	0.17	0.00	0.33
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	23.49	3.36	0.56	0.56	0.00
bladder, adult, pool1	10011-101C2	77.14	1.41	0.22	0.43	0.22
blood, adult, pool1	10053-101G8	48.72	2.21	0.00	2.21	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	27.40	3.43	1.71	0.00	0.00
bone marrow, adult	10192-103E3	47.24	0.00	2.02	1.35	0.00
brain, adult, donor1	10084-102B3	54.33	2.05	3.08	9.23	2.05
brain, adult, pool1	10012-101C3	52.56	4.23	3.45	4.68	1.78
brain, fetal, pool1	10085-102B4	69.46	2.67	0.00	8.01	0.00
breast carcinoma cell line:MCF7	10482-107A5	62.77	0.66	1.32	1.65	0.66
breast carcinoma cell line:MDA-MB-453	10419-106C5	35.95	0.87	1.12	1.25	0.25
breast, adult, donor1	10080-102A8	62.50	3.16	0.00	0.63	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	25.41	2.67	1.02	1.14	0.00
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	20.41	1.24	0.62	0.62	0.31
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	19.11	0.23	0.92	0.23	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	23.48	0.73	0.24	0.73	0.73
carcinoid cell line:NCI-H1770	10703-109H1	27.74	0.94	0.47	1.88	0.47
carcinoid cell line:NCI-H727	10735-110B6	35.99	0.88	1.09	0.22	0.33
carcinoid cell line:SK-PN-DW	10719-109I8	18.38	1.90	0.32	0.32	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	42.32	3.73	1.86	0.80	0.00
caudate nucleus - adult, donor10196	10177-103C6	33.39	2.30	2.30	3.45	2.30
caudate nucleus, adult, donor10252	10164-103B2	53.54	4.35	1.84	1.67	1.00
caudate nucleus, adult, donor10258	10379-105H1	48.14	3.82	1.53	5.35	3.06
caudate nucleus, newborn, donor10223	10354-105E3	52.74	3.66	1.46	3.66	0.00
cerebellum - adult, donor10196	10173-103C2	81.57	0.00	5.83	8.74	2.91
cerebellum, adult, donor10252	10166-103B4	101.42	1.07	3.20	5.98	1.71
cerebellum, adult, pool1	10083-102B2	68.30	2.07	2.41	6.21	1.03
cerebellum, newborn, donor10223	10357-105E6	126.20	0.83	4.98	4.15	0.00
cerebral meninges, adult	10188-103D8	41.86	3.53	2.52	2.52	0.25
cerebrospinal fluid, donor2	10294-104G6	11.69	0.00	2.19	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	49.03	1.87	0.58	1.58	0.29
cervical cancer cell line:ME-180	10553-107I4	42.59	2.15	0.00	0.50	0.50
cervix, adult, pool1	10013-101C4	90.82	0.73	0.84	0.42	0.31
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	40.83	1.39	1.81	1.53	1.11
chondrosarcoma cell line:SW 1353	10700-109G7	11.76	1.31	1.31	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	38.40	2.49	0.12	0.00	0.12
choriocarcinoma cell line:SCH	10785-110H2	14.42	0.49	0.37	0.74	0.00
choriocarcinoma cell line:T3M-3	10618-108G6	26.09	3.56	1.42	0.47	0.95
chorionic membrane cells, donor1	12238-129G6	69.24	3.99	0.85	0.57	2.56
chorionic membrane cells, donor2	12239-129G7	60.75	5.27	1.29	0.20	2.39
chorionic membrane cells, donor3	12240-129G8	64.29	2.75	0.00	0.55	0.55
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	26.25	1.01	2.02	3.03	1.01
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	21.71	2.69	0.38	0.96	0.77
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	9.29	0.21	0.63	0.21	0.42
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	11.81	0.26	0.26	0.26	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	11.37	0.73	0.00	0.00	0.24
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	14.86	0.41	0.00	0.00	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	11.78	0.00	1.47	0.00	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	15.64	0.26	0.52	0.52	0.26
clear cell carcinoma cell line:JHOC-5	10638-108I8	27.20	0.23	0.69	1.37	0.46
clear cell carcinoma cell line:TEN	10636-108I6	31.40	1.21	0.87	0.69	0.17
colon carcinoma cell line:CACO-2	10513-107D9	32.40	1.10	0.73	0.73	0.92
colon carcinoma cell line:COLO-320	10420-106C6	42.95	0.76	0.76	0.00	0.76
colon, adult, donor1	10082-102B1	63.07	3.57	1.19	2.38	1.19
colon, adult, pool1	10014-101C5	81.19	2.70	1.29	0.35	0.82
colon, fetal, donor1	10070-101I7	47.59	1.24	0.00	0.00	0.00
common myeloid progenitor CMP, donor1	12130-128D6	82.50	0.00	0.00	4.58	0.00
common myeloid progenitor CMP, donor2	12134-128E1	100.15	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	13.17	1.27	0.00	0.85	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	18.41	0.91	0.15	0.30	0.45
cord blood derived cell line:COBL-a untreated	10449-106F8	22.42	0.71	0.85	0.42	0.00
corpus callosum, adult, pool1	10042-101F6	56.72	2.32	1.11	1.22	0.44
cruciate ligament, donor2	10295-104G7	22.69	0.00	0.00	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	31.30	0.00	0.00	0.00	0.80
diencephalon, adult	10193-103E4	42.96	2.64	3.12	1.68	2.16
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	15.38	0.23	0.69	0.69	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	17.18	0.77	1.03	0.00	0.26
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	22.63	0.48	0.24	0.72	0.48
ductus deferens, adult	10196-103E7	72.76	0.00	1.00	0.50	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	43.21	5.76	2.88	1.44	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	60.32	4.41	2.21	1.47	0.00
dura mater, adult, donor1	10041-101F5	40.80	1.49	0.50	0.41	0.58
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	71.06	3.11	0.67	0.44	2.22
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	41.70	1.72	0.86	0.86	0.14
embryonic pancreas cell line:1B2C6	10604-108F1	12.95	1.85	1.23	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	13.32	0.30	0.91	0.00	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	12.35	0.93	0.93	0.31	0.31
embryonic pancreas cell line:2C6	10603-108E9	21.02	0.00	2.63	0.00	1.31
endometrial carcinoma cell line:OMC-2	10497-107C2	35.20	2.01	1.01	0.67	2.01
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	32.44	0.18	0.72	1.27	0.18
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	28.62	1.13	1.29	1.13	0.64
epidermoid carcinoma cell line:A431	10426-106D3	33.35	1.22	0.67	0.22	0.33
epidermoid carcinoma cell line:Ca Ski	10431-106D8	15.51	1.10	0.22	0.55	0.00
epididymis, adult	10197-103E8	46.89	1.26	0.63	0.63	0.42
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	23.95	0.18	1.06	0.71	0.00
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	17.70	1.57	1.57	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	39.05	1.44	1.05	0.79	0.79
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	39.96	1.57	0.79	1.97	1.08
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	39.55	1.79	1.46	0.78	1.01
esophagus, adult, pool1	10015-101C6	70.29	2.23	0.32	0.53	0.11
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	23.67	0.88	1.13	1.75	0.25
eye - muscle inferior rectus, donor1	10272-104E2	48.29	0.00	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	25.25	0.00	2.10	2.10	0.00
eye - muscle medial, donor2	10299-104H2	20.84	1.49	2.98	1.49	0.00
eye - muscle superior, donor2	10297-104G9	26.37	0.00	3.44	0.00	1.15
eye - vitreous humor, donor1	10268-104D7	10.20	0.00	1.46	0.00	0.00
eye, fetal, donor1	10054-101G9	75.00	2.03	1.53	2.03	0.76
fibrosarcoma cell line:HT-1080	10758-110E2	13.46	0.26	0.90	0.90	0.00
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	18.76	1.90	0.00	0.71	0.00
frontal lobe, adult, pool1	10040-101F4	43.82	4.69	4.60	5.54	1.88
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	29.42	0.30	0.60	0.60	0.30
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	25.33	1.10	0.73	0.46	0.09
gall bladder, adult	10198-103E9	68.08	0.72	0.48	0.97	0.48
gamma delta positive T cells, donor1	11937-126A2	75.70	0.00	1.61	1.07	0.00
gamma delta positive T cells, donor2	11938-126A3	51.92	0.37	0.75	0.37	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	35.70	4.01	0.42	0.63	1.06
gastric adenocarcinoma cell line:MKN45	10612-108F9	35.78	0.97	0.97	0.97	0.77
gastric cancer cell line:AZ521	10549-107H9	18.36	0.66	3.28	0.82	0.66
gastric cancer cell line:GSS	10560-108A2	14.64	0.00	0.92	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	39.07	2.06	1.60	0.91	0.46
giant cell carcinoma cell line:LU65	10487-107B1	11.93	0.80	0.00	0.00	0.11
giant cell carcinoma cell line:Lu99B	10433-106E1	18.33	1.12	0.14	0.00	0.28
glassy cell carcinoma cell line:HOKUG	10688-109F4	28.43	1.00	0.25	0.25	0.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	38.42	2.43	0.84	0.95	0.42
glioblastoma cell line:A172, tech_rep2	10444-106F3	37.64	3.23	1.26	0.84	1.26
glioblastoma cell line:T98G	10485-107A8	27.92	1.77	0.33	0.88	0.33
glioma cell line:GI-1	10413-106B8	34.56	2.64	1.46	2.93	1.17
globus pallidus - adult, donor10196	10175-103C4	24.05	1.46	2.19	0.73	1.46
globus pallidus, adult, donor10252	10161-103A8	47.60	2.20	0.73	1.46	0.98
globus pallidus, adult, donor10258	10367-105F7	24.65	0.00	0.00	0.00	1.37
globus pallidus, newborn, donor10223	10364-105F4	42.63	1.07	3.73	0.53	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	92.99	7.34	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	54.64	0.00	10.93	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	26.13	5.23	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	25.92	0.96	1.28	0.32	0.64
hIPS +CCl2, biol_rep1	14383-156B9	32.60	0.92	1.84	0.46	0.92
hIPS +CCl2, biol_rep2	14384-156C1	24.69	1.83	0.46	0.00	0.00
hIPS +CCl2, biol_rep3	14385-156C2	28.34	1.29	0.00	0.00	1.29
hIPS, biol_rep1	14380-156B6	18.68	0.00	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	32.24	1.37	0.00	0.69	0.69
hIPS, biol_rep3	14382-156B8	20.97	2.21	4.41	4.41	1.10
hairy cell leukemia cell line:Mo	10712-109I1	12.93	0.29	0.00	0.00	0.00
heart - mitral valve, adult	10205-103F7	43.05	2.09	0.90	2.39	0.30
heart - pulmonic valve, adult	10206-103F8	46.02	0.78	0.52	1.57	0.00
heart - tricuspid valve, adult	10207-103F9	68.28	6.66	1.67	1.67	2.50
heart, adult, diseased post-infarction, donor1	10050-101G5	46.93	1.22	0.82	1.63	0.00
heart, adult, diseased, donor1	10051-101G6	71.11	2.13	2.98	5.54	0.43
heart, adult, pool1	10016-101C7	63.24	1.15	1.15	2.07	0.46
heart, fetal, pool1	10046-101G1	66.84	1.64	1.33	1.85	0.72
hepatic mesenchymal tumor cell line:LI90	10778-110G4	30.54	1.85	1.54	1.23	0.31
hepatoblastoma cell line:HuH-6	10633-108I3	24.97	1.19	0.00	2.38	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	44.97	2.54	0.66	0.77	0.55
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	45.39	1.70	1.21	0.73	0.73
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	44.67	2.12	1.62	1.01	0.81
hepatoma cell line:Li-7	10484-107A7	24.02	1.33	0.33	0.33	0.89
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	12.56	0.30	0.60	0.20	0.10
hippocampus - adult, donor10196	10169-103B7	23.66	0.95	0.00	5.68	1.89
hippocampus, adult, donor10252	10153-102I9	44.09	1.63	1.43	2.25	0.61
hippocampus, adult, donor10258	10374-105G5	25.89	2.99	2.49	3.49	0.00
hippocampus, newborn, donor10223	10363-105F3	43.35	4.58	1.41	4.23	0.70
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	56.15	1.83	1.22	0.00	0.61
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	38.68	2.55	1.18	0.20	0.98
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	47.22	2.03	0.51	0.00	0.25
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	36.09	2.26	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	39.51	1.29	0.52	0.77	0.26
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	44.79	0.76	0.38	0.38	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	32.41	1.75	1.75	0.58	0.29
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	31.88	1.94	1.08	0.43	0.43
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	34.20	1.67	2.50	0.00	0.83
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	29.36	1.18	1.42	0.24	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	25.07	1.77	1.13	0.32	0.32
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	22.89	1.35	1.35	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	38.65	1.56	0.78	0.47	0.94
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	33.90	0.49	0.49	0.00	1.97
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	53.24	0.87	0.87	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	49.83	2.48	0.57	0.76	0.76
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	40.99	2.18	0.87	0.44	0.44
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	51.98	1.50	0.50	0.50	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	34.66	1.51	0.94	0.38	0.38
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	42.29	0.91	0.91	1.36	0.45
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	39.47	1.25	0.31	0.31	0.31
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	34.78	1.80	1.47	0.33	0.49
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	33.97	0.58	1.16	0.87	0.58
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	30.49	1.49	1.49	0.30	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	44.34	1.85	0.92	0.92	0.92
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	43.36	2.57	1.14	0.29	2.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	61.25	2.45	0.41	0.82	1.63
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	45.77	1.41	0.00	1.76	0.35
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	42.44	1.27	1.27	0.32	0.32
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	48.42	2.12	0.61	0.91	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	27.92	2.07	1.55	0.52	0.52
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	32.54	1.33	1.33	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	27.96	0.51	0.26	0.51	0.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	29.91	0.77	1.02	1.02	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	27.26	0.76	1.51	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	29.91	0.34	0.34	1.34	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	47.09	2.17	0.72	0.24	1.93
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	54.37	1.78	0.89	1.34	0.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	44.88	1.95	0.98	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	44.93	2.44	0.92	0.00	0.92
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	32.53	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	57.91	0.99	0.99	0.00	0.33
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	36.67	1.64	1.09	1.64	1.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	33.66	0.36	0.36	0.36	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	29.54	0.36	0.00	0.36	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	19.09	0.00	3.58	0.00	1.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	30.34	1.35	1.22	0.41	0.41
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	22.90	1.35	1.08	0.54	0.27
immature langerhans cells, donor1	11904-125F5	12.35	0.24	0.48	0.00	0.00
immature langerhans cells, donor2	11905-125F6	15.05	0.79	0.00	0.79	0.00
insula, adult, pool1	10039-101F3	54.51	3.88	5.20	7.76	2.18
keratoacanthoma cell line:HKA-1	10791-110H8	83.89	9.75	0.33	0.65	0.33
kidney, adult, pool1	10017-101C8	67.89	1.40	1.80	1.20	0.50
kidney, fetal, pool1	10045-101F9	82.05	2.76	1.56	1.34	0.50
large cell lung carcinoma cell line:IA-LM	10509-107D5	40.62	1.56	0.99	0.71	0.99
large cell lung carcinoma cell line:NCI-H460	10839-111E2	28.89	0.55	1.66	0.55	0.14
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	7.52	0.37	0.37	0.73	0.18
left atrium, adult, donor1	10079-102A7	49.04	2.18	1.63	2.18	0.00
left ventricle, adult, donor1	10078-102A6	47.03	0.51	0.51	2.02	0.51
leiomyoblastoma cell line:G-402	10721-110A1	10.12	0.82	1.09	0.55	0.27
leiomyoma cell line:10964C	10569-108B2	53.89	2.87	2.51	2.16	0.36
leiomyoma cell line:15242A	10570-108B3	46.74	4.89	4.35	6.52	0.54
leiomyoma cell line:15425	10571-108B4	44.68	3.16	3.16	2.43	0.73
leiomyosarcoma cell line:Hs 5.T	10722-110A2	50.79	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	28.23	0.00	0.00	1.05	1.05
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	18.18	0.59	1.06	1.53	0.24
liposarcoma cell line:KMLS-1	10782-110G8	32.65	2.50	1.87	1.25	1.56
liposarcoma cell line:SW 872	10726-110A6	22.42	1.58	1.10	0.85	0.49
liver, adult, pool1	10018-101C9	94.64	5.51	1.94	0.65	2.43
liver, fetal, pool1	10086-102B5	35.75	1.88	0.00	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	28.58	1.60	1.60	1.90	0.73
locus coeruleus, adult, donor10252	10165-103B3	46.32	1.29	1.48	1.85	1.48
locus coeruleus, adult, donor10258	10375-105G6	54.45	1.97	2.82	1.41	0.56
locus coeruleus, newborn, donor10223	10362-105F2	47.53	1.26	0.00	0.42	0.42
lung adenocarcinoma cell line:A549	10499-107C4	29.48	0.97	0.55	0.42	0.42
lung adenocarcinoma cell line:PC-14	10408-106B3	57.91	1.38	0.00	0.69	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	32.95	1.45	0.53	0.40	0.00
lung, adult, pool1	10019-101D1	62.02	1.77	0.59	0.12	1.06
lung, fetal, donor1	10068-101I5	66.21	2.00	1.43	0.86	0.29
lung, right lower lobe, adult, donor1	10075-102A3	43.99	1.83	1.37	0.92	0.92
lymph node, adult, donor1	10077-102A5	34.08	0.47	0.95	0.47	0.00
lymphangiectasia cell line:DS-1	10727-110A7	15.56	0.88	1.32	0.22	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	13.43	0.15	1.21	0.45	0.30
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	33.13	0.00	0.00	0.00	0.85
mature adipocyte, donor1	12231-129F8	78.59	3.11	0.44	0.00	0.44
mature adipocyte, donor2	12232-129F9	73.46	3.94	0.42	0.00	0.83
mature adipocyte, donor3	12233-129G1	66.38	2.37	0.24	0.00	0.24
mature adipocyte, donor4	12234-129G2	62.65	1.05	0.79	0.00	0.79
maxillary sinus tumor cell line:HSQ-89	10414-106B9	39.79	0.95	2.38	0.95	0.71
medial frontal gyrus - adult, donor10196	10170-103B8	45.12	4.51	3.38	10.15	1.13
medial frontal gyrus, adult, donor10252	10150-102I6	43.77	1.84	2.02	2.94	2.21
medial frontal gyrus, adult, donor10258	10368-105F8	40.35	4.45	6.04	6.35	1.27
medial frontal gyrus, newborn, donor10223	10352-105E1	50.33	0.85	0.85	0.85	0.43
medial temporal gyrus - adult, donor10196	10183-103D3	60.75	3.21	3.21	7.43	1.18
medial temporal gyrus, adult, donor10252	10156-103A3	46.69	1.91	2.12	3.61	0.85
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	38.53	0.00	5.78	1.93	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	28.71	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	65.33	2.87	2.87	4.67	0.36
medulla oblongata - adult, donor10196	10174-103C3	27.91	0.65	1.95	1.95	1.30
medulla oblongata, adult, donor10252	10155-103A2	41.02	1.08	0.93	1.39	1.08
medulla oblongata, adult, pool1	10038-101F2	44.90	2.69	2.61	1.71	0.90
medulla oblongata, newborn, donor10223	10361-105F1	48.95	1.39	2.08	2.08	0.00
medulloblastoma cell line:D283 Med	10838-111E1	43.40	0.22	0.89	0.66	0.00
medulloblastoma cell line:ONS-76	10759-110E3	19.81	1.22	1.59	0.12	0.24
melanoma cell line:COLO 679	10514-107E1	33.21	3.16	0.43	0.72	0.57
melanoma cell line:G-361	10465-106H6	26.33	1.63	0.81	1.09	1.36
meningioma cell line:HKBMM	10691-109F7	24.42	1.81	0.00	0.18	0.00
merkel cell carcinoma cell line:MKL-1	10843-111E6	30.84	2.64	1.76	2.64	0.88
merkel cell carcinoma cell line:MS-1	10844-111E7	39.14	3.89	1.04	1.81	0.78
mesenchymal precursor cell - adipose, donor1	11747-123G1	38.67	2.92	0.46	0.31	1.07
mesenchymal precursor cell - adipose, donor2	11748-123G2	26.90	2.00	0.36	0.18	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	32.71	1.66	0.83	0.83	0.41
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	32.31	3.37	1.40	0.98	1.12
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	46.02	3.47	0.77	0.77	2.31
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	49.97	1.39	0.69	0.69	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	44.11	2.06	1.20	1.54	1.37
mesenchymal precursor cell - cardiac, donor2	11753-123G7	44.86	4.14	0.58	1.15	1.04
mesenchymal precursor cell - cardiac, donor3	11754-123G8	31.17	2.92	0.40	1.19	0.53
mesenchymal precursor cell - cardiac, donor4	11755-123G9	42.67	2.84	1.62	0.81	1.49
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	28.31	2.85	1.14	0.57	0.85
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	30.63	0.99	0.66	0.33	0.66
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	19.93	2.63	0.42	0.69	0.69
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	33.16	1.05	1.40	1.40	0.35
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	31.03	1.22	0.82	1.63	0.82
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	25.16	1.08	1.44	2.16	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	22.35	1.76	0.72	1.03	0.52
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	35.57	1.60	1.82	1.14	0.23
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	30.21	0.42	2.10	0.84	1.26
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	28.09	2.84	0.75	1.05	0.15
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	17.94	1.66	0.44	0.44	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	22.83	0.74	1.47	0.74	0.74
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	20.60	1.72	1.72	1.43	0.29
mesenchymal stem cell line:Hu5/E18	10568-108B1	18.95	1.26	2.11	0.84	0.42
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	51.15	0.46	0.46	0.91	1.37
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	47.32	1.02	1.28	1.53	0.77
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	48.42	1.05	1.83	1.57	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	42.52	1.54	0.62	1.54	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	42.13	3.06	2.12	1.65	0.71
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	45.01	1.69	2.37	0.68	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	42.05	2.75	1.18	1.96	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	36.61	0.00	0.46	0.93	0.93
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	96.61	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	48.17	1.73	1.15	0.58	0.29
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	38.60	1.56	0.89	2.01	0.45
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	47.35	2.16	1.44	1.20	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	32.27	0.00	0.00	2.93	0.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	44.31	1.01	1.01	1.68	0.67
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	41.76	1.64	1.64	2.87	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	45.53	1.29	0.86	1.72	1.29
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	32.81	0.00	2.73	2.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	30.99	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	43.52	3.25	0.32	0.97	0.97
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	45.10	5.82	1.45	1.45	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	46.38	2.13	2.67	0.53	1.07
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	31.08	0.82	1.64	0.82	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	47.04	0.39	2.33	1.17	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	35.68	0.00	0.00	2.10	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	31.79	2.98	0.99	0.00	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	33.37	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	41.51	1.78	0.59	1.19	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	48.74	0.00	1.22	1.22	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	38.64	0.63	1.90	1.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	49.32	3.79	1.38	1.03	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	60.18	2.15	0.00	2.15	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	59.88	3.99	3.99	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	96.43	3.44	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	70.90	4.07	0.00	1.63	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	74.68	7.94	2.38	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	76.05	5.90	1.18	1.77	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	80.11	4.05	1.56	1.56	1.87
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	66.83	6.68	0.00	1.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	61.50	3.55	1.18	1.18	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	87.31	2.57	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	65.40	4.13	2.07	3.44	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	40.57	2.47	2.47	0.49	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	32.52	1.12	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	36.89	2.54	0.64	0.64	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	38.69	1.61	0.00	0.40	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	30.53	8.72	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	34.21	0.00	2.53	0.00	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	30.34	2.43	0.61	0.00	1.21
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	36.15	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	37.07	1.65	0.82	0.82	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	47.03	1.59	2.58	0.60	1.19
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	44.78	3.89	1.62	0.97	0.97
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	48.89	3.06	0.00	3.06	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	27.85	0.00	1.55	1.55	1.55
mesothelioma cell line:ACC-MESO-1	10493-107B7	36.85	1.65	0.71	1.18	0.24
mesothelioma cell line:ACC-MESO-4	10494-107B8	24.56	1.39	1.16	1.39	0.46
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	42.74	0.00	0.00	0.00	4.27
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	40.79	0.82	0.72	0.31	0.00
mesothelioma cell line:Mero-25	10850-111F4	35.63	2.04	0.91	0.00	0.23
mesothelioma cell line:Mero-41	10851-111F5	33.49	0.98	1.22	1.22	0.24
mesothelioma cell line:Mero-48a	10852-111F6	21.26	1.77	1.33	1.11	0.22
mesothelioma cell line:Mero-82	10853-111F7	34.69	1.58	0.53	0.00	0.26
mesothelioma cell line:Mero-83	10854-111F8	20.09	0.85	0.68	1.19	0.17
mesothelioma cell line:Mero-84	10855-111F9	25.78	0.76	1.01	0.51	0.00
mesothelioma cell line:Mero-95	10856-111G1	48.66	2.69	2.90	2.07	0.62
mesothelioma cell line:NCI-H2052	10847-111F1	26.01	1.82	1.49	0.50	0.50
mesothelioma cell line:NCI-H226	10846-111E9	14.48	1.09	0.18	0.36	0.00
mesothelioma cell line:NCI-H2452	10848-111F2	20.50	1.02	0.00	0.00	0.34
mesothelioma cell line:NCI-H28	10845-111E8	19.85	0.00	1.27	0.25	0.00
mesothelioma cell line:No36	10857-111G2	19.57	0.33	0.33	0.33	0.00
mesothelioma cell line:ONE58	10858-111G3	19.24	1.08	0.00	1.08	0.27
migratory langerhans cells, donor1	11901-125F2	7.29	0.00	0.58	0.38	0.00
migratory langerhans cells, donor2	11902-125F3	11.85	0.12	1.22	0.73	0.12
migratory langerhans cells, donor3	11903-125F4	11.85	0.36	0.90	0.00	0.36
mixed mullerian tumor cell line:HTMMT	10689-109F5	19.92	0.98	0.33	0.00	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	19.92	1.27	1.48	1.27	0.00
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	8.29	0.46	0.23	0.00	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	21.69	2.09	0.19	0.19	0.00
myelodysplastic syndrome cell line:SKM-1	10772-110F7	35.66	2.03	0.37	0.18	1.11
myeloma cell line:PCM6	10474-106I6	33.80	1.98	0.59	0.00	0.20
myxofibrosarcoma cell line:MFH-ino	10600-108E6	18.26	0.51	3.04	0.51	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	83.75	10.59	0.59	0.39	3.73
nasal epithelial cells, donor1, tech_rep1	12226-129F3	26.85	1.00	0.22	0.22	0.11
nasal epithelial cells, donor1, tech_rep2	12226-129F3	28.24	1.25	0.22	0.15	0.07
nasal epithelial cells, donor2	12227-129F4	16.56	0.00	0.00	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	35.43	6.90	1.38	0.23	1.84
neuroblastoma cell line:NB-1	10539-107G8	29.37	2.06	2.06	1.68	1.12
neuroblastoma cell line:NBsusSR	10607-108F4	24.88	6.33	0.63	0.84	3.16
neuroblastoma cell line:NH-12	10555-107I6	36.34	1.68	0.56	0.00	0.75
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	17.32	0.95	0.00	0.47	0.24
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	23.92	2.69	0.16	0.32	0.79
neuroectodermal tumor cell line:TASK1	10774-110F9	12.28	0.60	0.81	0.20	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	17.17	4.45	0.00	0.64	0.64
neurofibroma cell line:Hs 53.T	10729-110A9	24.75	1.06	1.86	0.80	0.27
neutrophil PMN, donor1	12133-128D9	431.37	14.87	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	79.68	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	66.29	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	33.82	2.20	0.68	0.00	1.01
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	42.43	4.00	1.60	0.80	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	40.08	1.60	1.28	2.24	1.28
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	45.46	2.36	1.31	1.31	1.05
nucleus accumbens, adult, pool1	10037-101F1	44.99	4.22	2.91	4.97	1.41
occipital cortex - adult, donor10196	10172-103C1	39.15	2.06	2.06	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	48.31	2.68	1.88	1.88	0.00
occipital cortex, newborn, donor10223	10355-105E4	66.24	1.09	3.28	5.82	1.82
occipital lobe, adult, donor1	10076-102A4	48.02	3.94	5.25	6.04	2.10
occipital lobe, fetal, donor1	10073-102A1	47.20	3.86	1.29	3.43	0.43
occipital pole, adult, pool1	10036-101E9	49.99	5.12	3.39	6.07	1.81
olfactory region, adult	10195-103E6	42.80	4.01	3.44	4.39	1.15
optic nerve, donor1	10277-104E7	46.02	2.00	0.00	2.00	2.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	42.26	3.08	1.48	1.25	1.94
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	34.48	1.51	0.41	0.14	0.41
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	22.18	1.02	0.34	0.17	0.17
oral squamous cell carcinoma cell line:SAS	10544-107H4	31.65	3.47	0.69	0.12	1.16
osteoclastoma cell line:Hs 706.T	10704-109H2	31.16	1.47	0.88	0.59	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	25.23	0.00	0.93	0.93	1.87
osteosarcoma cell line:HS-Os-1	10558-107I9	12.51	0.42	1.27	1.06	0.21
ovary, adult, pool1	10020-101D2	80.28	2.80	0.96	0.79	1.92
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	12.83	1.10	1.28	1.10	0.18
pancreas, adult, donor1	10049-101G4	58.32	0.94	0.00	0.94	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	26.84	1.12	1.96	0.84	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	27.77	2.21	1.02	0.34	0.68
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	24.01	0.83	0.66	0.00	0.33
paracentral gyrus, adult, pool1	10035-101E8	47.23	3.94	3.75	6.86	2.20
parietal cortex, adult, donor10258	10373-105G4	24.22	3.67	2.94	2.94	0.00
parietal lobe - adult, donor10196	10171-103B9	45.14	1.88	5.64	5.64	0.94
parietal lobe, adult, donor10252	10157-103A4	38.77	3.14	2.00	2.85	1.14
parietal lobe, adult, pool1	10034-101E7	43.71	3.17	4.32	6.96	2.47
parietal lobe, fetal, donor1	10072-101I9	34.91	1.94	0.97	4.85	2.91
parietal lobe, newborn, donor10223	10356-105E5	52.34	2.24	1.87	2.62	0.00
parotid gland, adult	10199-103F1	77.70	1.23	1.85	0.62	0.00
penis, adult	10200-103F2	65.53	1.07	1.07	1.61	1.07
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	21.01	0.00	0.93	0.37	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	27.83	1.46	1.02	0.87	0.29
pineal gland - adult, donor10196	10179-103C8	52.89	1.29	4.52	3.87	1.94
pineal gland, adult, donor10252	10160-103A7	59.22	1.18	3.55	5.92	0.59
pineal gland, adult, donor10258	10377-105G8	45.15	1.88	5.64	5.02	0.63
pituitary gland - adult, donor10196	10180-103C9	34.40	0.00	1.01	2.02	2.02
pituitary gland, adult, donor10252	10162-103A9	56.29	2.08	3.13	1.56	1.56
pituitary gland, adult, donor10258	10378-105G9	57.03	0.85	0.85	1.70	0.85
placenta, adult, pool1	10021-101D3	78.58	2.80	0.22	0.11	1.08
plasma cell leukemia cell line:ARH-77	10840-111E3	19.20	0.79	0.53	0.13	0.00
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	45.45	3.58	1.25	0.31	1.71
pons, adult, pool1	10033-101E6	37.01	2.24	3.18	4.22	2.41
postcentral gyrus, adult, pool1	10032-101E5	54.31	5.67	4.27	5.93	2.70
promyelocytes/myelocytes PMC, donor1	12132-128D8	100.39	4.18	0.00	2.09	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	38.56	5.51	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	46.94	0.00	23.47	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	21.12	0.29	1.46	1.89	0.29
prostate cancer cell line:PC-3	10439-106E7	27.77	1.63	1.27	0.54	0.00
prostate, adult, pool1	10022-101D4	73.73	1.90	0.63	0.73	0.45
putamen, adult, donor10196	10176-103C5	54.29	5.19	2.83	6.85	4.49
putamen, adult, donor10252	10152-102I8	64.70	5.88	3.92	1.96	1.96
putamen, adult, donor10258, tech_rep1	10372-105G3	28.41	3.28	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	43.01	6.28	3.38	4.35	0.97
putamen, newborn, donor10223	10365-105F5	41.98	0.00	1.50	0.75	0.75
rectal cancer cell line:TT1TKB	10469-106I1	25.60	1.16	0.29	0.29	0.29
rectum, fetal, donor1	10067-101I4	61.20	2.78	2.78	0.00	1.39
renal cell carcinoma cell line:OS-RC-2	10411-106B6	35.83	1.06	1.70	0.21	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	23.20	0.00	0.00	0.00	0.00
retina, adult, pool1	10030-101E3	70.67	1.89	1.89	1.59	0.70
retinoblastoma cell line:Y79	10475-106I7	40.01	1.82	1.82	1.56	0.52
rhabdomyosarcoma cell line:KYM-1	10787-110H4	10.57	0.61	0.61	0.49	0.49
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	20.53	0.56	0.56	0.00	1.12
sacrococcigeal teratoma cell line:HTST	10695-109G2	46.99	3.79	0.76	0.76	0.00
salivary acinar cells, donor1	11771-123I7	28.00	0.81	0.65	0.16	0.32
salivary acinar cells, donor2	11772-123I8	32.49	0.83	0.55	0.14	0.00
salivary acinar cells, donor3	11773-123I9	41.71	1.99	0.00	0.00	0.00
salivary gland, adult, pool1	10093-102C3	56.05	0.57	1.72	2.29	0.57
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	16.02	1.10	0.42	0.51	0.17
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	16.22	1.29	0.24	0.12	0.24
seminal vesicle, adult	10201-103F3	53.44	1.59	0.00	0.53	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	18.46	1.21	1.94	1.21	0.24
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	27.68	2.01	0.75	0.00	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	24.08	2.01	3.01	3.01	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	61.65	3.22	0.54	0.40	1.61
signet ring carcinoma cell line:Kato III	10436-106E4	21.33	1.77	0.55	0.11	0.22
signet ring carcinoma cell line:NUGC-4	10483-107A6	27.87	2.32	0.65	0.26	0.00
skeletal muscle - soleus muscle, donor1	10282-104F3	15.61	0.00	0.00	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	38.38	1.92	0.00	0.48	1.20
skeletal muscle, fetal, donor1	10066-101I3	11.06	1.01	1.01	0.00	0.00
skin, adult, donor1	10074-102A2	67.85	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	35.35	0.63	0.00	0.63	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	49.69	9.67	3.00	0.67	1.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	42.24	1.89	0.32	0.63	0.95
small cell lung carcinoma cell line:DMS 144	10841-111E4	33.73	0.00	1.73	2.89	0.19
small cell lung carcinoma cell line:LK-2	10541-107H1	23.90	1.48	0.49	0.33	0.33
small cell lung carcinoma cell line:NCI-H82	10842-111E5	33.46	0.32	0.32	0.48	0.16
small cell lung carcinoma cell line:WA-hT	10562-108A4	68.64	9.81	1.96	2.40	1.96
small intestine, adult, pool1	10024-101D6	77.76	4.06	0.72	0.60	0.60
small intestine, fetal, donor1	10064-101I1	29.73	1.23	1.23	1.97	0.49
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	78.47	4.10	1.54	2.05	1.54
smooth muscle, adult, pool1	10048-101G3	53.50	2.33	0.26	0.00	0.26
somatostatinoma cell line:QGP-1	10781-110G7	46.37	3.48	0.27	0.27	0.54
spinal cord - adult, donor10196	10181-103D1	32.35	0.69	1.38	1.15	0.23
spinal cord, adult, donor10252	10159-103A6	28.39	1.97	0.79	0.39	0.79
spinal cord, adult, donor10258	10369-105F9	26.98	0.69	1.38	0.69	0.00
spinal cord, fetal, donor1	10056-101H2	48.18	1.83	1.83	2.44	1.83
spinal cord, newborn, donor10223	10359-105E8	61.53	2.30	1.84	2.76	0.46
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	22.25	1.64	0.15	1.05	0.45
spleen, adult, pool1	10025-101D7	48.24	1.65	0.11	0.22	0.22
spleen, fetal, pool1	10044-101F8	60.47	2.78	1.11	0.40	0.64
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	13.56	0.41	0.21	0.10	0.00
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	23.35	0.57	0.00	0.00	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	34.25	0.35	1.05	0.00	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	38.70	0.78	1.95	0.00	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	31.18	1.13	1.91	2.03	0.11
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	79.21	1.69	3.39	0.85	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	16.50	0.85	1.27	1.27	0.85
stomach, fetal, donor1	10062-101H8	56.60	1.07	0.00	2.14	1.07
submaxillary gland, adult	10202-103F4	49.56	1.71	0.57	0.00	0.00
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	43.83	2.28	0.00	0.42	0.42
substantia nigra, adult, donor10258	10371-105G2	25.86	1.55	2.59	2.59	0.00
substantia nigra, newborn, donor10223	10358-105E7	40.98	1.41	1.41	2.12	0.71
synovial sarcoma cell line:HS-SY-II	10441-106E9	39.66	1.83	2.29	1.83	0.46
temporal lobe, adult, pool1	10031-101E4	64.17	4.58	4.49	6.02	2.71
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	42.74	4.99	0.71	0.71	0.71
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	40.44	3.52	2.64	0.88	0.44
tenocyte, donor1	11763-123H8	86.23	2.44	1.75	1.40	1.75
tenocyte, donor2	11765-123I1	101.10	5.34	1.53	2.29	2.67
tenocyte, donor3	11768-123I4	70.80	4.08	1.11	4.82	0.37
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	16.15	1.70	0.68	0.85	2.72
teratocarcinoma cell line:NCR-G1	10798-110I6	22.66	0.77	0.46	0.00	0.77
teratocarcinoma cell line:PA-1	10807-111A6	21.54	0.77	0.93	0.77	0.93
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	34.02	3.17	0.38	0.51	1.40
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	40.09	1.89	0.38	0.76	0.38
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	32.61	1.42	0.65	0.44	0.76
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	42.67	0.65	0.33	0.00	0.00
testis, adult, pool1	10026-101D8	60.67	1.72	0.75	0.86	0.32
testis, adult, pool2	10096-102C6	32.03	0.00	1.35	0.90	0.00
thalamus - adult, donor10196	10168-103B6	41.95	0.00	3.31	1.10	2.21
thalamus, adult, donor10252	10154-103A1	40.32	2.03	1.25	0.94	0.31
thalamus, adult, donor10258, tech_rep1	10370-105G1	24.63	3.08	1.54	3.08	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	30.47	1.32	2.80	2.31	0.99
thalamus, newborn, donor10223	10366-105F6	42.57	1.73	3.45	2.30	0.58
throat, adult	10209-103G2	38.20	0.75	0.50	0.75	0.25
throat, fetal, donor1	10061-101H7	42.35	1.22	0.91	0.91	0.30
thymic carcinoma cell line:Ty-82	10803-111A2	17.29	0.60	2.58	2.38	0.00
thymus, adult, pool1	10027-101D9	59.25	3.98	1.49	0.70	1.39
thymus, fetal, pool1	10043-101F7	48.73	3.32	0.52	0.62	0.73
thyroid carcinoma cell line:KHM-5M	10776-110G2	24.33	3.32	0.27	0.66	0.13
thyroid carcinoma cell line:TCO-1	10783-110G9	27.38	1.12	0.70	0.28	0.28
thyroid, adult, pool1	10028-101E1	104.14	2.24	0.37	1.77	0.93
thyroid, fetal, donor1	10060-101H6	53.26	2.11	0.53	2.37	0.53
tongue epidermis (fungiform papillae), donor1	10288-104F9	43.11	0.00	6.16	0.00	0.00
tongue, adult	10203-103F5	35.35	0.00	0.00	0.47	0.00
tongue, fetal, donor1	10059-101H5	42.96	1.18	0.00	1.18	0.00
tonsil, adult, pool1	10047-101G2	41.07	1.20	0.50	0.50	0.10
trachea, adult, pool1	10029-101E2	56.36	1.96	0.57	0.41	0.74
trachea, fetal, donor1	10058-101H4	41.93	1.92	0.38	0.77	0.38
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	40.74	1.06	0.71	1.06	0.71
transitional-cell carcinoma cell line:5637	10418-106C4	16.82	0.91	0.30	0.00	0.20
transitional-cell carcinoma cell line:JMSU1	10492-107B6	18.96	0.31	1.72	0.94	0.63
tridermal teratoma cell line:HGRT	10694-109G1	41.86	1.90	3.81	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	27.17	2.45	0.93	0.42	0.42
umbilical cord, fetal, donor1	10057-101H3	39.64	0.00	0.00	2.09	0.00
uterus, adult, pool1	10100-102D1	52.72	2.39	0.34	0.68	0.51
uterus, fetal, donor1	10055-101H1	36.35	1.54	2.56	0.00	1.02
vagina, adult	10204-103F6	71.08	3.88	0.65	0.65	0.65
vein, adult	10191-103E2	48.00	0.66	1.10	0.88	0.44
xeroderma pigentosum b cell line:XPL 17	10563-108A5	7.48	0.00	0.00	0.00	0.00